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ABSTRACT 
  
 The presence and activity of glutathione S-transferase alpha 3 (GSTA3) in the 
testosterone biosynthesis pathway of humans and multiple mammalian species is a new 
concept.  Some researchers have hypothesized that the gene encoding GSTA3 is 
conserved across many other species.  This study undertakes characterization of the 
GSTA3 gene products in multiple diverse species in order to demonstrate its 
conservation.  The species analyzed here include Canis lupus familiaris, Capra hircus, 
Monodelphis domestica, and Gallus gallus.  Testis samples from each of these species 
were taken, RNA was isolated, reverse transcribed, and the GSTA3 cDNA was cloned 
and sequenced with polymerase chain reaction (PCR) technologies.  cDNA sequences 
were then analyzed with the NCBI BLAST algorithm, ExPASy Translate tool, and 
Clustal Omega Multiple Sequence Alignment tool.  These tools were also used to 
compare  the cloned cDNAs to a reference sequence from Homo sapiens (GenBank 
accession number XM_000847.4) and an Equus caballus sequence published in the 
NCBI database (KC512384).  GSTA3 cDNA sequences obtained for each species were 
submitted to NCBI GenBank.  A set of multiple tissue samples was taken from both 
Equus caballus and Canis lupus familiaris.  These tissue samples were analyzed for the 
expression of GSTA3 mRNA in each tissue after RNA isolation, reverse transcription 
and quantitative polymerase chain reaction (qRT-PCR).  cDNA data analysis 
demonstrated GSTA3 gene conservation at the DNA level in all the species studied.  
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Real time quantitative PCR data demonstrated significantly high concentrations of the 
GSTA3 mRNA in the testes and adrenal glands as compared to all other tissues for the 
equine multi-tissue analysis as expected.  Dissimilarly, the canine multiple tissue 
analysis indicated that the concentration of GSTA3 mRNA was high in the liver and 
small intestine as well as the testes and adrenal glands.  Other researchers have reported 
high concentrations of GSTA3 mRNA in the liver and small intestine previously.  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NOMENCLATURE 
11B-HSD1 11-beta hydroxysteroid dehydrogenase type 1 
11B-HSD2 11-beta hydroxysteroid dehydrogenase type 2 
BLAST Basic Local Alignment Search Tool  
BSA Bovine Serum Albumin 
ChIP  Chromatin Immunoprecipitation Assay 
GSH Glutathione 
GST Glutathione S-transferase 
GSTA3 Glutathione S-transferase Alpha 3 
GSTP Glutathione S-transferase Pi 
GSTM Glutathione S-transferase Mu 
HSD3B2 hydroxy-delta-5-steroid dehydrogenase, 3 beta-steroid delta-
  isomerase 2 
HSD17B3  hydroxysteroid (17-beta) dehydrogenase 3  
NC Negative Control 
NCBI    National Center for Biotechnology Information 
PCR Polymerase Chain Reaction  
qRT-PCR Real Time Quantitative Polymerase Chain Reaction 
SF-1 Steroidogenic factor 1 
SNP Single Nucleotide Polymorphism 
StAR Steroid Acute Regulatory Protein 
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 Although the testosterone biosynthesis pathway is well studied there are still gaps 
in our knowledge and understanding of its mechanisms (Agular et al., 1992; 
Badrinarayanan et al., 2006; Board, 1998; Diemer et al., 2003; Gu et al., 2004; 
Gunasekar et al., 1988; Herrera-Luna et al., 2012, 2013; Ing, 2005; Johansson and 
Mannervik, 2001, 2002; Kanzaki and Morris, 1999; Laughlin et al., 2010; Namiki et al., 
1991; Payne and Hales, 2004; Payne and Youngblood, 1995; Tars et al., 2010; Yoon and 
Roser, 2011).  Testosterone is produced by the Leydig cells of the testis from cholesterol 
through the actions of a series of enzymes.  Species specificity has been demonstrated in 
the steroidogenic pathways, with rodent species utilizing the Δ4 pathway and human and 
livestock species utilizing the Δ5 pathway (Johansson and Mannervik, 2001, 2002; 
Larsson et al., 2011).  It has been discovered that human and livestock species employ 
the enzyme glutathione S-transferase alpha 3 (GSTA3) as a steroid isomerase to convert 
△5-androstenedione  to  △4-androstenedione, the immediate precursor of testosterone 
(Calvaresi et al., 2012; Dourado et al., 2014; Gu et al., 2004; Hayes et al., 2005; 
Johansson and Mannervik, 2001, 2002; Matsumura et al., 2013; Raffalli-Mathieu et al., 
2008).  Recombinant human GSTA3 has been demonstrated to be 260 times more 
efficient in isomerizing Δ5-androstenedione to Δ4-androstenedione than HSD3B2, the 
enzyme to which this activity was previously attributed (Dourado et al., 2014; Johansson 
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and Mannervik, 2001, 2002; Larsson et al., 2011; Matsumura et al., 2013; Morel et al., 
2002).  
 There is little information related to the regulation of the GSTA3 gene and its 
actions in steroidogenesis.  This is in part due to the fact that the GSTA3 gene is only 
highly expressed in steroidogenic tissues.  In addition, GSTA3 is a member of a large 
family of highly related GSTA genes clustered on one chromosome. The gene products 
are difficult to distinguish from one another, and they are all also expressed in Leydig 
cells as well as other tissues (Board, 1998; Dourado et al., 2014; Johansson and 
Mannervik, 2001, 2002; Larsson et al., 2011; Luu-The, 2013; Morel et al., 2002).  
Further research to elucidate which species utilize GSTA3 is of great importance.  
Evidence has been provided that a synthetic glucocorticoid, similar to natural stress 
hormones, has a suppressive effect on the expression of the GSTA3 enzyme in stallion 
testes (Ing et al., 2015).  Considering most of our food production animals are housed in 
confinement type operations which are generally very stressful environments, it is 
necessary to understand the regulation of the GSTA3 gene and the role of the GSTA3 
enzyme in testosterone biosynthesis.  To this aim, many researchers have utilized the 
corticosteroid drug dexamethasone to mimic stress in research animals in order to study 
its effects on testosterone production.  A few researchers have focused specifically on the 
effects of glucocorticoids like dexamethasone and its effects on steroidogenesis 
(Badrinarayanan et al., 2006; Barth and Bowman, 1994; Danek, 2004; Hardy et al., 
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2005; Ing et al., 2014, 2015; Wang and Stocco, 2005; Xiao et al., 2010).  However, few 
studies have focused on determining the evolutionary  conservation of  the GSTA3 gene 
across species.  The following project will examine the GSTA3 mRNA expression in the 
testis and other body tissues, as well as the specific coding sequence and sequence 
conservation between multiple species, which will include Equus caballus, Canis lupus 
familiars and Capra hircus, as well as divergent species, Monodelphis domestica and 
Gallus gallus.  These data will provide a more thorough understanding of the GSTA3 
gene products and their regulation of expression. 
  The purpose of this study is to: 
    provide further evidence that the GSTA3 gene is most highly expressed in 
   the gonads and adrenal glands, as well as elucidate and compare the GSTA3 
   cDNA sequence across species such as Homo sapiens, Equus caballus, Canis 
   lupus familiaris, Capra hircus, Monodelphis domestica, Gallus gallus. 
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CHAPTER II  
LITERATURE REVIEW 
Steroidogenesis 
 Physiological, pathological and developmental processes are brought about by 
the actions of steroid hormones.  These hormones consist of estrogens, androgens, 
progestogens, mineralocorticoids and glucocorticoids (Almadhidi et al., 1995; Carreau et 
al., 2001; Conley and Bird, 1997; Evain et al., 1976; Gummow et al., 2006; Ing, 2005; 
Johansson and Mannervik, 2001; Kanzaki and Morris, 1999; King and LaVoie, 2012; 
Namiki et al., 1991; Payne and Hales, 2004; White, 2003).  The biosynthesis of these 
hormones is referred to as steroidogenesis, which is a complex multiple enzyme process 
utilizing cholesterol as the starting material (Eacker et al., 2008;  Fedulova et al., 2010; 
Jo et al., 2005; Kanzaki and Morris, 1999; King and LaVoie, 2012; Luu-The, 2013; 
Payne and Hales, 2004; Parker and Schimmer, 1997; Svechnikov et al., 2010).  This 
process is generally carried out in the adrenal glands, placenta and gonads.  The 
development of a thorough understanding of the reactions which occur in 
steroidogenesis is crucial to the advancement of treatments for a number of medical 
conditions (Agular et al.,1992; Buren et al., 2002; Diemer et al., 2003; Evain et al., 1976; 
Fahrenholtz et al, 2013; Hardy et al., 2005; Herrera-Luna et al., 2012, 2013; Jo et al., 
2005; Kanzaki and Morris, 1999; Larsson et al., 2011; Reddy et al., 2009; Svechnikov et 
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al., 2010).  A large gap in our current understanding of this process exists in the effects 
of glucocorticoids on the production of androgens and estrogens.  One way to fill this 
gap is by understanding steroidogenesis as a whole, and then by evaluating the effects of 
changes in the pathways under specific conditions.  This can be accomplished through 
extensive research and comparison of the mechanisms of steroidogenesis in numerous 
species. 
 The existence of alternative metabolic routes for steroidogenesis, and that the 
preference for a specific pathway can vary between species has long been known  
(Conley and Bird, 1997; Preslock and Steinberger, 1978).  With exponential gains in 
technology in recent years the ability to thoroughly evaluate this topic is within 
researchers’ grasp.  Determination of species-specific pathways can not only provide 
insight into the physiology of the species, but also provide vital information about 
pathological conditions like polycystic ovarian disease, castration resistant prostate 
cancer, hirsutism, and congenital adrenal hyperplasia to name a few diseases 
characterized by increased androgen production (Conley and Bird, 1997; Lei et al., 2001; 
Parker and Schimmer, 1997; Svechnikove et al., 2010; White, 2003; Ye et al., 2011).  
These insights may also elucidate the mechanisms behind infertility and aging.  The 
ability to make comparisons between species and their preferred pathways can allow 
researchers to choose more appropriate species when planning a project and thus derive 
more applicable data. 
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 For many years scientists have been compiling data on steroidogenesis.  In a 
study on steroid metabolism in testis tissue, Ruokonen and Vihko (1974) demonstrated 
similarities between the boar and the human. Researchers studied the conversion of 
cholesterol to pregnenolone in bovine adrenocortical mitochondrial acetone-dried 
powder preparations, recognizing the importance of pregnenolone as a cornerstone of 
androgen and estrogen synthesis in cattle (Burstein and Gut, 1976).   A few years later, 
Preslock and Steinberger (1978) noted a preference for the △4 pathway of testosterone 
biosynthesis in marmosets.  Studies into steroidogenesis have also noted its importance 
in follicle development in female mammals (Conley et al., 1994), as well as an 
interrelationship between the function of the gonads and the adrenal glands (Conley and 
Bird, 1997; deKretser et al., 1998; Eacker et al., 2008; Gummow et al., 2006; King and 
LaVoie, 2012; Lei et al., 2001; Martel et al., 1994; Parker and Schimmer, 1997; Payne 
and Youngblood, 1995).  More recently researchers have made connections between 
lowered steroidogenesis and proinflammatory factors, obesity, heart disease, aging, and 
impaired skeletal health (Blouin et al., 2006; Bonavera et al., 1998; Conley and Bird, 
1997; Hong et al., 2004; Karsenty, 2012; Lei et al., 2001; Payne and Youngblood, 1995; 
Sartorius et al., 2012; Sipahutar et al., 2003; Svechnikov et al., 2010; Wang and Stocco, 
2005; White, 2003).  These studies indicate that adequate steroid levels are required for 
normal development and function of the body, whether it is human, horse, or any other 
species. 
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Testosterone is a highly studied and well-known androgen.  It is required for 
masculinization and reproductive functions in male mammals, including sperm 
production (Diemer et al., 2003; Gunasekar et al., 1988; Hess and Franca, 2008; 
Laughlin et al., 2010; Lopez-Calderon et al., 1991; Payne and Youngblood, 1995; 
Svechnikov et al., 2010; Yoon and Roser, 2010).  Aberrant production levels of 
testosterone are strongly linked to conditions such as infertility,  hyperandrogenism and 
hypogonadism among others (deKretser et al., 1998; Hardy et al., 2005; Hess and 
Franca, 2008; Laughlin et al., 2010; Svechnikov et al., 2010; Yoon and Roser, 2010).  
Recognition of this association has increased research in avian species and their 
respective methods of steroidogenesis and hormone regulation (London, 2006; 
Matsunaga et al., 2002; Rangel et al., 2007; Tsutsui et al., 2010; Yu et al., 1995).  The 
elucidation of an array of steroid hormone dependent physiological processes has 
provided a link between avian and mammal reproductive physiology and a need for 
further research. 
Through elucidation of the mechanisms which regulate testosterone biosynthesis, 
a better understanding of many complex steroid hormone dependent disorders can be 
found (Cooke et al., 1991; Gunasekar et al., 1988; Ing, 2005; Johansson and Mannervik, 
2001, 2002; Laughlin et al., 2010; Lei et al., 2001; Lopez-Calderon et al., 1991; Luu-
The, 2013; Namiki et al., 1991).  Many studies have targeted this topic, finding that 
production of testosterone is largely decreased by the presence of glucocorticoids 
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(Agular et al., 1992; Badrinarayanan et al., 2006; Cartmill et al., 2006; Hardy et al., 
2005; Hu et al., 2008; Ing et al., 2014,2015; Yoon and Roser, 2010).  Also products of 
steroidogenesis, glucocorticoids are produced by the adrenal glands during times of 
stress (Badrinarayanan et al., 2006; Buren et al., 2002; Gummow et al., 2006; Herrera-
Luna et al., 2013; Quax et al., 2013).  Glucocorticoids are also widely used as 
pharmaceuticals to treat conditions involving inflammation (Cooke et al., 1991; 
Cornelisse et al., 2004; Grady et al., 2010; Liu et al., 2011; Quax et al., 2013).  The 
mechanism by which glucocorticoids impair testosterone biosynthesis is still unknown, 
but the effects of stress on testosterone production are well documented (Eacker et al., 
2008; Hardy et al., 2005; Lopez-Calderon et al., 1991).  Many researchers have 
investigated this glucocorticoid mediated suppression of steroidogenesis in the rat and 
identified targets for this action (Agular et al., 1992; Cooke et al., 1991; Welsh et al., 
1982; Xiao et al., 2010).  A few of the targets identified include 3beta-hydroxysteroid 
dehydrogenase (HSD3B2), steroidogenic acute regulatory protein (StAR), and 17a- 
hydroxylase (CYP17A1) (Agular et al., 1992; Welsh et al., 1982; Xiao et al., 2010).  
Continued research into suppression of steroidogenesis via glucocorticoid driven 
mechanisms will increase scientists’ understanding of their actions in health and disease. 
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Glutathione S-transferase alpha 3 
 Until recently, the isomerization of Δ5-androstenedione to Δ4-androstenedione, 
the immediate precursor to testosterone in the biosynthetic pathway (Figure 1), was 
attributed to the HSD3B2 enzyme (Badrinarayanan et al., 2006; Matsumura et al., 2013;  
Raffalli-Mathieu et al., 2008).  It has now been demonstrated that glutathione S-
transferase alpha 3 (GSTA3) is 260 times more efficient at this action than HSD3B2 in 
humans (Johansson and Mannervik, 2001).   GSTA3 is a member of a family of GSTAs 
which are well known for their actions in detoxification (Benbrahim-Tallaa et al., 2002; 
Board, 1998; Calvaresi et al., 2012; Gu et al., 2004; Johansson and Mannervik, 2001, 
2002; Liu et al., 1993; Matsumura et al., 2013; Morel et al., 2002; Norrgard et al., 2006; 
Petterson et al., 2002; Prabhu et al., 2004).  The GSTAs are isoenzymes of the GST 
family.  Specifically GSTAs are in the cytosolic class, which also includes glutathione S-
transferase pi (GSTP) and mu (GSTM) (Dourado et al., 2010, 2014; Fedulova et al., 
2010; Higgins and Hayes, 2011; Liu et al., 1993; Norggard et al., 2006; Prabhu et al., 
2004).  All GSTs act in detoxifying a number of toxic substances by catalyzing their 
conjugation to glutathione and are found in a number of tissues throughout the body in 
varying concentrations, with high levels of GSTA and GSTP in the testis (Benbrahim-
Tallaa et al., 2002; Fedulova et al., 2010; Hayes et al., 2005; Norggard et al., 2006).   
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  Detoxification by GSTs targets compounds containing an electrophilic carbon, 
nitrogen, or sulphur atom (Hayes et al, 2005; Sarkar et al., 2001).  These toxins include 
chemical carcinogens, antibiotics, anticancer agents, environmental pollutants, and 
products of oxidative processes which cause damage to DNA and proteins (Benbrahim-
Tallaa et al., 2002; Prabhu et al., 2004; Sarkar et al., 2001; Tars et al., 2010; Ye et al., 
2011).  GST structure and biochemical composition determine their affinity for a specific 
substrate and are distinct between the isoenzymes.  Their activity has also been shown to 
be regulated at a transcriptional level, with effects from follicle stimulating hormone 
(FSH), testosterone, and estradiol, as well as pharmaceuticals like phenobarbital 
(Benbrahim-Tallaa et al., 2002; Hayes et al, 2005; Higgins and Hayes, 2011).  
Specifically, treatment of cultures of porcine Sertoli cells with testosterone increased 
GSTA mRNAs in a dose-dependent and time dependent manner, while treatment with 
FSH also increased GSTA mRNAs in a dose-dependent manner (Benbrahim-Talla et al., 
2002).  Both treatments increased expression of GSTA proteins (Benbrahim-Talla et al., 
2002).  It was also determined that FSH increased the stability of GSTA mRNAs, but 
testosterone did not (Benbrahim-Talla et al., 2002).  With high levels of GSTA gene 
expression in testis, the known effects of oxidative stress on spermatogenesis, and 
mounting evidence of the higher efficiency of the GSTA3 enzyme relative to the 
HSD3B2 enzyme in the isomerization of Δ5-androstenedione to Δ4-androstenedione in 
testosterone biosynthesis of humans, it is necessary to further understand GSTA gene 
regulation and actions of the gene products (Calvaresi et al., 2012; Johansson and 
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Mannervik, 2001, 2002; Larsson et al., 2011; Raffalli-Mathieu et al., 2008; Sarkar et al., 
2001; Tars et al., 2010).  
 The family of GSTA genes is clustered on the same chromosome and their 
protein products are almost indistinguishable (Johansson and Mannervik, 2001, 2002; 
Larsson et al., 2011; Morel et al., 2002; Petterson et al., 2002).  Further research has 
revealed that the coding sequence of human GSTA3 mRNA is 92% identical to that of 
GSTA1 and is 91% identical to that of GSTA2 (Larsson et al., 2011).  GSTA4 mRNA 
shares the least similarity with only 59% identity to the coding sequence of GSTA3 
mRNA (Johansson and Mannervik, 2002; Larsson et al., 2011; Morel et al., 2002).     
 The critical amino acid residues for the 3-ketosteroid isomerase activity of 
GSTA3, within its 222 amino acid length, were experimentally determined and are 
presented below in Table 1 for Homo sapiens (Dourado, et al., 2014; Johansson and 
Mannervik, 2002; Petterson et al., 2002).  Critical amino acids for other species were 
determined through comparison of identity by the BLASTX algorithm with the reference 
sequences from the NCBI database to the human (NM_000847.4) reference GSTA3 
mRNA sequence.  NCBI sequences (Equus caballus NM_001283076.1, Canis lupus 
familiaris XM_532173.4, Capra hircus XM_005696424.1, Monodelphis domestica 
XM_001370694.3, and Gallus gallus NM_204818.2) yielding high identity at the 
protein level were aligned for the location of the human critical amino acids.  These 
residues are located in the active site of the GSTA3 enzyme which has two regions, the 
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glutathione binding site (G-site) which binds glutathione, and the hydrophobic binding 
site (H-site) which binds to the steroid substrate (Calvaresi et al., 2012; Dourado et al., 
2014; Gu et al., 2004; Johansson and Mannervik, 2001; Petterson et al., 2002; Tars et al., 
2010).  The amino acid sequences of the GSTAs also share high sequence identity.  
GSTA1 and GSTA3 differ at 20 of 222 amino acid residues, revealing 91% identity 
between the two sequences (Johansson and Mannervik, 2001; Larsson et al., 2011).   
GSTA2 and GSTA4 share 88% identity (26 residues different out of 222) and 54% 
identity with GSTA3, respectively (Gu et al., 2004; Johansson and Mannervik, 2001; 
Larsson et al., 2011).  
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Table 1 
Critical amino acids (AA) for 3-ketosteroid isomerase activity of GSTA3.  The critical 
amino acids for the human GSTA3 protein were experimentally determined by Dourado et 
al., 2014, Johansson and Mannervik, 2002, and Petterson et al., 2002.  Other species’ 
critical amino acids were located by the alignment of the human GSTA3 protein translation 
from NCBI reference sequence NM_000847.4 with protein translations of the reference 
sequences for horse (NM_001283076.1), dog (XM_532173.4), goat (XM_005696424.1), 
opossum (XM_001370694.3), and chicken (NM_204818.2). 
AA Position: #9 #10 #12 #111 #208 #216
Homo sapiens Y F G L A A
Equus caballus Y F G I G S
Canis lupus 
familiaris
Y F G L L A
Capra hircus Y F G L T A
Monodelphis 
domestica
Y F G L M A
Gallus gallus Y V G F P V
 Despite their high identity, the human GSTA3 enzyme exhibits steroid isomerase 
activity 10-fold higher than the human GSTA1 enzyme (Calvaresi et al., 2012; Dourado 
et al., 2014).  However, the human GSTA1 enzyme does exhibit some steroid isomerase 
activity in conjugation with the human GSTA3 enzyme (Gu et al., 2004; Matsumura et 
al., 2013).  Research has demonstrated the human GSTA3 enzyme is activated by 
steroidogenic factor one (SF-1) which induces a chromosomal conformational change, 
bringing the promoters of human GSTA3 and GSTA1 into close proximity, at which 
point the human GSTA3 promoter functions as an enhancer for human GSTA1 
(Matsumura et al., 2013).  Many studies have investigated the role of the GSTAs in 
species besides the human.  Raffalli-Mathieu and colleagues (2007) cloned and 
expressed bovine GSTA1 for comparison to human GSTA3.  Their investigation 
demonstrated high amino acid sequence identity and selective expression in 
steroidogenic organs, four out of five residues critical for steroid isomerase activity were 
conserved, but the enzyme’s catalytic efficiency in steroid isomerization was 100 times 
lower than that of human GSTA3.  However, the catalytic efficiency in steroid 
isomerization of bovine GSTA1 was equal to that of bovine HSD3B.   
 The catalytic efficiency of the porcine GSTA2 enzyme as a steroid isomerase was 
evaluated in another study (Fedulova et al., 2010).  In this investigation the porcine 
GSTA2 enzyme, like the bovine GSTA1 enzyme, was cloned, expressed, and its catalytic 
activity was compared to the human GSTA3 enzyme.   Porcine GSTA2, unlike bovine 
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GSTA1, was determined to be an analog of the human GSTA3 enzyme (Fedulova et al., 
2010).  There were significant similarities between human GSTA3 and porcine GSTA2 
in steroid isomerase activity and selective expression pattern for steroidogenic tissues.  
The isomerase activity of porcine GSTA2 was lower than that of human GSTA3, but 
higher than human GSTA1 steroid isomerase activity.  It was demonstrated that porcine 
GSTA2 and human GSTA3 have 84% identity in their amino acid coding sequences and 
both demonstrate inhibition by the endocrine disruptor tributyltin chloride (Fedulova et 
al., 2010). Characterization of the GSTA3 gene products is far from complete and many 
other species may demonstrate conservation of the GSTA3 gene and its isomerase 
activity. 
 The activity and specificity for these residues was investigated in human GSTAs 
by cloning and bacterial expression procedures. Specific point mutations switched 
GSTA2 residues into GSTA3 protein at the specified critical positions (Johansson and 
Mannervik, 2002; Petterson et al., 2002).  Activity of the GSTA3 enzyme with the 
steroid substrate was determined to be most affected by mutation of residues at amino 
acid position 10 phenylalanine (F), 111 leucine (L), and 216 alanine (A).  Substitution of 
residue 216 alanine with serine (S) showed little effect on isomerase activity, but 
mutations in residues 10, 111, and 216 combined dropped the enzymatic activity to 0.8% 
that of the wild-type (Johansson and Mannervik, 2002).  A single nucleotide base change 
in a codon for the amino acid serine can elicit the change of that serine to a threonine 
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(T), proline (P), or alanine (A), thus creating an isozyme if the enzyme function is 
unaltered.  Amino acid residues with similar chemical properties to those of the native 
human GSTA3 protein are unlikely to alter overall function of the enzyme. 
 Although the sequences of the 12 human GSTA genes and pseudogenes are well 
documented, the GSTA gene sequences of other species are usually omitted during 
genome sequence assembly (Matsumura et al., 2013; Morel et al., 2002).  This tendency 
is due to the sequence similarity of the GSTAs and the use of computer programs to 
assemble the genome from short sections based on paired-end reads and overlapping 
regions.  Often, the whole genome shotgun sequencing approach is used to generate 
millions of sequence reads with a high level of redundancy (6X or more) in order to 
improve accuracy of assembly.  Short, repeated or highly similar sequences which 
cannot be organized into a contig are considered inconsistencies or gaps and are left out 
of the sequence for further review.  Elucidation and documentation of these sequences 
will allow for further analysis of the GSTA3 mechanism of action in testosterone 
biosynthesis, and provide sequence identity data between species.  Across species 
comparison is an extremely valuable commodity when determining appropriate 
experimental models.  Previous research has indicated that the glucocorticoid 
dexamethasone represses expression of the GSTA3 gene in horse testis (Ing et al., 2014, 
2015).  Studies involving exogenous glucocorticoids like dexamethasone have also 
clearly indicated down-regulation of testosterone biosynthesis, adding evidence to the 
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hypothesis that these effects are mediated by the repression of the GSTA3 gene (Barth 
and Bowman, 1994; Cartmill et al., 2006; Ing et al., 2015).  
Glucocorticoids 
Glucocorticoids are cholesterol derivatives produced by steroidogenesis in the 
adrenal glands.  They act as endocrine regulators and are well known for their actions 
during stress (Cooke et al., 1991; Hardy et al., 2005; Kizaki et al., 1998; Liu et al., 2011; 
Lopez-Calderon et al., 1991; Schmidt et al., 2010; Surjit et al., 2011).  Functions of this 
family of steroids includes regulation of metabolism, embryogenesis, inflammatory 
responses, programmed cell death, cell proliferation and differentiation, behavior, 
neurobiology, and homeostasis (Bladh et al., 2005; Gold et al., 2012; Kizaki et al., 1998; 
Liu et al., 2011; Schmidt et al., 2010; Smith et al., 2010; Smoak et al., 2006).  
Glucocorticoids act on the glucocorticoid receptor (GR) and are regulated at the tissue 
level by two enzymes, HSD11B1 and 2 (Herrera-Luna et al., 2012, 2013; Hu et al., 
2008; Xiao et al., 2010).  In humans the HSD11B2 enzyme acts in the conversion of 
cortisol, the active glucocorticoid, to cortisone, a less active glucocorticoid, while 
HSD11B1 catalyzes the reverse reaction (Bladh et al., 2005; Liu et al., 2011; Yick-Lun 
So et al., 2007).  The glucocorticoid receptor gene is expressed in most cells and is very 
highly expressed in the Leydig cells of the testis (Herrera-Luna et al., 2012; Hu et al., 
2008; Ing, 2005; Liu et al., 2011; Lopez-Calderon et al., 1991; Quax et al., 2013).   
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A number of synthetic glucocorticoids have been developed as pharmaceuticals 
in order to take advantage of their many effects on physiology and pathology.  Synthetic 
glucocorticoids include prednisone, prednisolone, and dexamethasone.  These drugs treat 
a wide variety of conditions involving inflammation.  They exert their effects by binding 
the glucocorticoid receptor, which mediates transactivation and transrepression of target 
genes by binding regulatory regions as well as interacting with other transcription factors 
(Liu et al., 2011; Smoak et al., 2006; Surjit et al., 2011; Yick-Lun So et al., 2007). 
Specifically, dexamethasone can both up and down regulate genes involved in regulating 
inflammation, cell growth, and cell death (Liu et al., 2011).   It can also exert post-
transcriptional gene regulation inducing expression of microRNAs and decreasing the 
stability of specific mRNAs (Ing, 2005; Liu et al., 2011; Smith et al., 2010).  
Dexamethasone treatment of stallions causes an acute decrease in serum 
testosterone concentrations (Ing et al., 2014, 2015). Weeks later, there is a decrease in 
the number of normal, motile sperm (Danek, 2004).  In other species, dexamethasone 
induced  abnormalities include sperm morphology and biochemical composition (Barth 
and Bowman, 1994; Danek, 2004; Ing et al., 2014, 2015).  These effects are transient.  
The risk of decreased testosterone and semen abnormalities resulting in decreased 
fertility due to dexamethasone treatment elicits much interest from those in the animal 
breeding industries, causing a push for further elucidation of the mechanism behind 
these effects. 
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The Leydig cells are the primary site of testosterone synthesis and, thus, provide 
a link between the inhibitory effects of glucocorticoids on testosterone production 
because of the high concentration of GRs located there.  Also, the anti-inflammatory 
effects of glucocorticoids are induced by the up-regulation of inhibitors of inflammatory 
mediators and the repression of cytokine gene expression by transcriptional regulation 
and mRNA destabilization (Bladh et al., 2005; Grady et al., 2010; Ing, 2005; Quax et al., 
2013; Smith et al., 2010).  Dexamethasone, a frequently prescribed glucocorticoid, has 
been demonstrated to be 30 times as potent as endogenous cortisol, as well as having a 
longer duration of action than that of prednisolone, another frequently prescribed 
glucocorticoid (Cornelisse et al., 2004; Grady et al., 2010; Liu et al., 2011).  
Dexamethasone is generally prescribed for inflammatory diseases including encephalitis, 
arthritis, and recurrent airway obstruction in horses.  In humans, glucocorticoids are 
prescribed for treating asthma, rheumatoid arthritis, brain tumors, prostate cancer, and 
some side effects of chemotherapy in humans, as well as many other conditions 
(Cornelisse et al., 2004; Grady et al., 2010; Smoak et al., 2006).    
Dexamethasone is commonly used in research studies which focus on the 
physiology of the stress response of a research organism (Agular et al., 1992; Buren et 
al., 2002; Cartmill et al.,  2006; Haffner et al., 2009; Herrera-Luna et al., 2012, 2013; Ing 
et al., 2014, 2015; Smoak et al., 2006).   Researchers have demonstrated that 
dexamethasone treatment of stallions reduces the concentration of testosterone in the 
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circulation by 60% within 12 hours post-injection (Ing et al., 2014, 2015).  It was also 
demonstrated that GSTA3 mRNA concentrations in testes from that study decreased two 
fold at 12 hours post-injection (Ing et al., 2014).  Results with stallions clearly indicate 
that dexamethasone administration decreases testosterone and later, reproductive 
efficiency (Danek, 2004).  A study conducted in bulls by Barth and Bowman (1994) to 
analyze the effect of testicular heating and stress on spermatogenesis utilized 
dexamethasone as their method of mimicking stress.  This study showed that bulls 
treated with dexamethasone displayed significantly (p < 0.05) lower testosterone 
concentrations.  A marked increase in sperm defects was also displayed in 
dexamethasone treated bulls (Barth and Bowman, 1994).  This breadth of information 
provides ample justification for further research into steroidogenesis, the testosterone 
biosynthesis pathway, and the expression and regulation of the GSTA3 gene. 
Species Divergence and Gene Conservation 
 In-depth analyses of the compiled genome sequences for multiple species 
through the use of public databases like NCBI allows for the elucidation of orthologous 
genes. Utilization of molecular biology tools can organize data from genomic and 
genetic analysis projects.  The increasing number of published genomes functions as a 
useful resource for compiling the genomes of previously understudied species (Dong et 
al., 2013, Frings et al., 2012; Hillier et al., 2004; Sawai et al., 2010, Skinner et al., 2009; 
!20
Skoglund et al., 2011; Wade et al., 2009).  Numerous studies utilizing comparative 
genomics to determine the location, function and interactions of genes have been 
recently carried out.  Das and colleagues (2012) analyzed genomic imprinting in 
Monodelphis domestica as compared to the human and mouse in several specific genes 
and found a large degree of consistency.  A recent study focusing on the evolution of the 
marsupium utilized complete mitochondrial genome for phylogenetic analysis  of 
morphological features typical of marsupials to verify the classification of Monodelphis 
domestica and Myrmecopius fasciatus (Hermick et al., 2013).  Orlando and colleagues 
(2013) exploited the vast availability of equid fossil records for a comparison between 
the Middle Pleistocene, Late Pleistocene and multiple modern domestic horse breeds in 
order to further our knowledge of the evolution of Equus caballus.  Using this analysis it 
was proposed that the most recent common ancestor to all modern Equus caballus lived 
4.0 to 4.5 million years ago.  Connections were demonstrated between horse population 
evolution and environmental adjustments of grassland availability and temperature.  
These studies demonstrate the vast array of knowledge which can be achieved using 
cross species genetic and genomic comparisons, including analyzing the occurrence of 
gene conservation.  
 Comparative genomics studies typically utilize closely related species and 
divergent species are avoided because the data obtained would be more difficult to 
assess accurately for similarity.  However, this does not mean that divergent species will 
not have a specific gene of interest.  It is generally accepted that chickens (Gallus 
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gallus), and mammals diverged an estimated 310 million years ago (Shaul and Graur 
2002).  This estimate, like all others, varies based on the specific study and methods 
used.  For this reason, Shaul and Graur (2002) did an analysis of these inconsistencies 
based on the calibration points used, which resulted in the identification of  a new 
estimate of 393 million years ago with a 95% confidence interval of 315- 471 million 
years.  Placental and non-placental mammals are estimated to have diverged 150 million 
years ago (Das et al., 2012).  This demonstrates that opossums are more closely related 
to humans than chickens. The rodent - primate divergence date has been estimated at 110 
million years ago which fully supports the acknowledged relationship proximities 
between birds and humans or mice and humans (Shaul and Graur, 2002).  It is unclear 
whether rodents express a GSTA gene product with 3-ketosteroid isomerase activity.  A 
phylogenetic tree of relationships of vertebrate species with assembled genomes is 
displayed in Figure 2. 
 Examples of comparative genomics are not all necessarily recent, but the current 
availability of next generation sequencing and physical mapping options greatly 
increases the ease of execution and accuracy of this type of project.  The conservation of 
microsatellite sequences between cattle (Bos taurus), goats (Capra hircus) and fallow 
deer (Cervus dama) was demonstrated by Laurent Pepin and colleagues (1995).  This 
study revealed that roughly 40 percent of the microsatellites developed for and utilized 
in cattle genomics can be employed in the investigation of the Capra hircus genome and 
provide useful information in regards to the genetic diversity of Artiodactyla.   
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Figure 2 Phylogenetic relationships of vertebrate species with assembled 
genomes.  Species investigated here are boxed in green.  The goat is not 
shown.  Image taken from UCSC Genome Wiki, 2014 which was adapted 
from Miller et al., 2007.  Full information on citation in references. 
 Recently a study of the caprine genome by Dong and colleagues (2013) has 
provided a more thorough understanding of the genetic basis of complex traits and the 
effects of breed on phenotype.  Today there are more than 830 million goats of more than 
1,000 breeds kept around the world for purposes including milk, meat, and fiber 
production.  However, according to Dong and colleagues (2013) research has previously 
been hindered by the lack of a complete reference genome sequence despite the goat’s 
agricultural and biological importance.  Many other studies point out the importance of  
decoding the genomes of different species for the purpose of understanding gene 
function and expression, especially of those complex pathways involved in development 
and disease (Dong et al, 2013; Frings et al., 2012; Hermick et al., 2013; Hillier et al., 
2004; Sawai et al., 2010; Skinner et al., 2009; Wade et al., 2009). 
  Elucidation and comparison of genomes between different breeds of domestic 
dogs have also been identified as important areas of research for their ability to impart an 
understanding of the relationships between phenotypic diversity and morphological, 
physiological and behavioral traits, better known as breed characteristics (Lindblad-Toh 
et el., 2005; Skoglund et al., 2011).  Lindblad-Toh and colleagues (2005) utilized 
comparative genomics for insights into this topic and were able to map and verify 
numerous SNPs which will provide for more accurate location of genes responsible for 
diseases and traits of interest.  This study also made comparisons between the dog, 
human and mouse genomes, elucidating significant regions of similarity and providing 
evidence for the ability of cross species comparisons to identify genes involved in  
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physiological processes and causes of disease.  These studies are just a few of the 
numerous examples which identify the  suitability of cross species gene comparisons.  
Furthermore, demonstration of conservation between multiple species, especially those 
of a divergent nature, allows for identification of unique genes and functional non-
coding sequences, as well as increased accuracy of evolutionary relationships.  For these 
reasons the project described here utilizes a range of species of varying divergence in its 
investigation of the GSTA3 gene.  Demonstration of the conservation of this gene and its 
function over numerous species solidifies our understanding of its role in physiology and 
allows for selection of a specific species for laboratory experiments.  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CHAPTER III 
MATERIALS AND METHODS 
Tissue Samples 
 Tissue samples for this study were donated to the project by the Texas A&M 
College of Veterinary Medicine from animals which were sacrificed for teaching 
purposes.  Tissues consist of testes from multiple species including horse (Equus 
caballus), dog (Canis lupus familiaris), gray short-tailed opossum (Monodelphis 
domestica), chicken (Gallus gallus) and goat (Capra hircus). Multiple tissue samples 
from Equus caballus and Canis lupus familiaris consisting of adrenal gland, cerebrum, 
heart, hypothalamus, kidney cortex, liver, lung, mammary, ovary, skeletal muscle, small 
intestine, spleen, urinary bladder, and uterus were also used.  All dog tissues except the 
ovary and testis came from a twelve year old female black and tan hound.  The other 
tissues were collected from a seven year old and a ten year old red bone hound, while the 
testis tissue was collected from a two year old bulldog.  Equine tissues were collected 
from a sixteen year old paint mare and a four year old quarter horse cross stallion. 
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RNA Extraction 
 In order to isolate the desired mRNA sequence from the tissue, the RNA must 
first be extracted.  Tissue samples were snap frozen and stored at -80ºC.  0.5 g of each 
tissue sample was homogenized in 5 ml of room temperature Tripure solution (Roche 
Applied Science, USA) with a tissue homogenizer (Kinematica GmbH distributed by 
Brinkman Instruments, Westbury NY).  After the tissues were homogenized, the 
homogenized tissue samples were incubated at room temperature for five minutes, 
chloroform was added and samples were shaken vigorously.  Then the samples were 
incubated again at room temperature for five minutes.  A centrifuge was used to separate 
the phases and the aqueous phase was removed via pipette to a clean sample tube. RNA 
was precipitated from the aqueous phase by the addition of isopropanol and an 
incubation period.  Samples were again centrifuged. This time a pellet formed at the 
bottom of the sample tube. Washing the pellets in 75% ethanol removed remaining salts.  
The pellets were briefly air dried.  Finally, the RNA pellets from the tissue samples were 
dissolved in diethylpyrocarbonate (DEPC) treated H2O and then quantified for RNA 
concentration and purity using a Nanodrop Spectrophotometer, as well as assessed for 
quality on a 2100 Bioanalyzer (Agilent; Santa Clara, CA). 
 Concentration of RNA in each sample as determined by the Nanodrop 
spectrophotometer was used to calculate the volume of each sample to be used in the 
reverse transcription reaction.  Data obtained through the use of this process also yields a 
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measure of purity.  The spectrophotometer measures the absorbance of the sample at 260 
nm to determine the concentration of nucleic acids in solution, this is known as the A260.  
For RNA  an A260  of 1.0 is equal to a concentration of 40 µg ml-1.  The 
spectrophotometer can also act as an indicator of purity by measuring the A280, thus 
providing quantification by the A260/A280 ratio.  Pure RNA would have a value near 2.0 
for this ratio.  The 2100 Bioanalyzer by Agilent uses capillary electrophoresis to measure 
RNA integrity.  This is done by assessing intact RNAs as well as the presence or absence 
of degradation products.  The measure of integrity is quantified in the RNA integrity 
number (RIN).  The optimal RIN with no degradation products present would have a 
value of 10, whereas a sample which is almost completely degraded would have a value 
of 1.  Samples from this project were run on the 2100 Bioanalyzer Nano chip and had 
RIN values ranging from 7.7 to 9.4. 
Reverse Transcription 
 Using the isolated RNA, complementary DNA (cDNA) was produced by reverse 
transcription.  The cDNA is necessary for amplification by polymerase chain reaction 
(PCR).  Using the data from the Nanodrop the volume to be used of each tissue RNA 
sample was calculated.  RNA sample amounts for cloning used 500 ng of RNA and 
samples for real time quantitative PCR (qRT-PCR) used 100 ng of RNA.  Two master 
mixes were created, one master mix consisted of a random octamer and dT20 primers, 
and a second master mix consisted of 5X first strand buffer, 0.1M DTT, dNTP mix, and 
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Superasin (Life Technologies, Thermo Fisher Scientific, Inc.). Master mix one, nuclease-
free H2O (Life Technologies, Thermo Fisher Scientific, Inc.) and the RNA from each 
tissue sample was combined in a micro-centrifuge tube, vortexed, centrifuged for a short 
time, incubated in a heating block at 70ºC for five minutes, quickly chilled on ice and 
then centrifuged again.  Master mix two was then added to each sample tube, mixed 
gently and incubated at room temperature for two minutes. The Superscript II Reverse  
Transcriptase (Life Technologies, Thermo Fisher Scientific, Inc.) was then added, mixed 
via pipette and incubated at room temperature for 10 minutes.  The samples were then 
incubated at 42ºC for three hours.  Afterwards, the Superscript II Reverse Transcriptase 
was inactivated by heating at 70ºC for 15 minutes. 
Nested PCR 
 Polymerase Chain Reaction (PCR) is utilized for amplification of cDNA.  In this 
process the cDNA is denatured so that a primer can bind a specific target sequence and 
then prime polymerization by Taq DNA polymerase.  This process is repeated for 30 to 
40 cycles to generate a suitable amount of cDNA product.  The term “nested” is utilized 
when referring to multiple sets of PCR with different primers for each set.  The final 
primers must target a section of the intended product which is “inside” of the previous 
set, or the “outside” primers (Figure 3).  This technique is utilized in an attempt to 
increase the sensitivity and fidelity of the PCR reaction.   
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Inside sense primer Inside antisense primer
Nested PCR product
cDNA template
Figure 3 Diagram of nested polymerase chain reaction
 Nested PCR was chosen as the preferred protocol because of its tendency to 
increase the sensitivity of PCR and reduce the generation of non-specific products. For 
this protocol, two sets of PCR primers were created: one set of forward and reverse 
“outside” primers and one set of forward and reverse “inside” primers.  Creation of these 
primers was accomplished with analysis of the human GSTA3 mRNA (NM_000847.1) 
sequence which is well documented in the NCBI database, as well as by comparison to  
previous documentation of the equine GSTA3 mRNA sequence also located in the NCBI 
database (KC512384.1).  Separate sets of primers were made for cloning into each 
vector.  The pET-21a vector utilizes the BamHI endonuclease sequence (GGATCC) for 
the initiation of translation for expression and the insert sequence must be in frame for 
this to occur.  In order to ensure that our cDNA inserts would ligate in frame with the 
BamHI site we included the EcoRI endonuclease sequence (GAATTC), which is located 
directly next to the BamHI endonuclease site, at the 5’ end of the sense primers.  The 
Xho I endonuclease sequence (CTCGAG) was included at the 5’ end of the inside 
antisense primer to increase success of the ligation reaction.  Primers were ordered from 
Integrated DNA Technologies (IDT) and their sequences are in Table 2 for cloning into 
pCR2.1 and Table 3 for cloning into pET-21a.  
 The primary PCR reaction was performed with the set of “outside” primers 
designated for each species, the previously made cDNA template from each species, and 
a master mix consisting of nuclease free H2O, 10X Taq buffer, Ex Taq enzyme (Takara 
Bio Inc., Otsu, Shiga, Japan) and 2.5mM dNTPs.  Final sample volume was 50 µL. PCR  
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Table 2  
PCR primer sequences for cloning cDNAs into pCR2.1 (5’- 3’) GSTA3

















Table 3  
PCR primer sequences for cloning cDNAs into pET-21a (5’- 3’) GSTA3 
Lowercase letters designate an endonuclease sequence. 





















was performed in the thermal cycler (GeneAmp PCR System 9600, PerkinElmer, 
Norwalk, CT) for 30 cycles of 94oC denaturation for 15 seconds, 45oC annealing for 30 
seconds, and 72oC extension for one minute.  Finally, there was a 72oC hold for five 
minutes. The secondary PCR reaction was performed with the set of “inside” primers for 
each species, one tenth (5 µL) of the primary PCR reaction products and a similar master 
mix as the first.  Secondary PCR reaction samples were placed in the thermal cycler and 
run on the same settings as the Primary PCR reaction.  Secondary PCR reaction products 
were combined with 10X DNA dye and analyzed via gel electrophoresis.  A 1% agarose 
gel and a 0.8% low melting temperature (LMT) agarose gel made with ethidium bromide 
were run in 1X TAE buffer, with Lambda HindIII EcoR1 marker and 10X DNA dye at 
100 volts for 45 minutes.  Ethidium bromide-staining allowed visualization of the 
expected cDNA products, which were photographed.  Products were expected to be 
670-700 base pairs.  Bands were cut from lanes in the 0.8% LMT gel displaying 
expected cDNA products for use in ligation reactions.  
Plasmid Vector Cloning with pCR 2.1 
Ligation in pCR 2.1 
 The cDNA PCR product bands cut from the 0.8% LMT agarose gel for each 
species was melted at 70℃ for ten minutes and then cooled to 37℃. They were then 
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ligated to pCR 2.1 for use in the transformation of One Shot TOP10F’ chemically 
competent E. coli (TA Cloning Kit K2030-40, Life Technologies, Thermo Fisher 
Scientific Inc.).  Each ligation reaction was of a 10 µl volume, and were performed at 
15℃.  The concentrations of the reagents in each reaction varied depending on whether 
it was the maximum, minimum, or negative control.  Maximum reaction tubes received 
3 µl kit H2O, 1 µl 10X ligation buffer, 2 µl vector DNA, 3 µl cDNA insert, and 1 µl T4 
DNA ligase.  Minimum reaction tubes received 5 µl kit H2O, 1 µl 10X ligation buffer, 2 
µl vector DNA, 1 µl cDNA insert, and 1 µl T4 DNA ligase.  The negative control tubes 
received 6 µl kit H2O, 1 µl 10X ligation buffer, 2 µl vector DNA, no cDNA insert, and 1 
µl T4 DNA ligase.  All reaction tubes were then placed in the 15℃ block to incubate 
overnight. 
Transformation 
 After the ligation reactions, samples ligated to pCR 2.1 were utilized in 
transformation reactions with E. coli and spread on LB-Ampicillin plates and incubated 
at 37℃ overnight for colony growth.  Before the plates were spread with the 
transformation reactions they were spread with 80 µl 20 mg/ml 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (XGAL) and 4 µl 20 mg/ml Isopropyl β-D-1-
thiogalactopyranoside (IPTG).  The plates were then incubated at 37℃ while the 
transformation reactions were prepared.  Transformation reactions were prepared 
identically by placing 1 µl of each ligation into a specified competent cell tube and 
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incubated on ice for 30 minutes.  Competent cell tubes were then heat shocked at 42℃ 
for 20 seconds and placed on ice for two minutes.  Finally 950 µl of room temperature 
SOC broth was added to each competent cell tube and they were placed on a rocker in a 
37℃ incubator for one hour.  The plates were then spread with 200 µl of their designated 
competent cell tube and incubated at 37℃ overnight.  The next day colonies were 
counted and colonies from these plates were randomly chosen for overnight LB broth 
cultures.  Each colony collected from the LB-Ampicillin plates was cultured overnight in 
5 ml LB-Ampicillin broth at 37℃ with strong agitation.    
Plasmid Purification 
 The plasmid DNA from these cultures was purified using the QIAprep Spin Kit 
from Qiagen. To accomplish this the overnight cultures were centrifuged and the 
supernatant was removed and discarded.  The bacterial pellets were resuspended with 
250 µl of buffer P1 and transferred to 1.5 ml micro centrifuge tubes.  250 µl  of buffer P2 
was added to each sample tube and the tubes were then inverted four to six times to mix.  
Next, 350 µl of the buffer N3 was added and the sample tubes were inverted four to six 
times to mix. Samples were then centrifuged for ten minutes at 13,000 rpm.  The 
supernatant was then pipetted in QIA prep spin columns and centrifuged for 60 seconds.  
The flow through was discarded and the column was washed with 500 µl of buffer PB.  
Sample tubes were then centrifuged for 60 seconds and the flow through was again 
discarded.  Next, the column was washed with 750 µl of buffer PE and again centrifuged 
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for 60 seconds.  In order to remove any residual buffer the samples were centrifuged 
again for 60 seconds, and then the the column was placed into a clean 1.5 ml micro 
centrifuge tube.  Finally, 50 µl of buffer EB was placed into the center of each column 
and allowed to set for one minuted and then centrifuged for one minute. 
 The purified plasmid DNA samples were digested with EcoR1.  This was 
accomplished by combining 10 µl of plasmid sample with 7 µl nuclease free H2O, 2 µl 
10X H buffer, and 1µl EcoRI.  Reactions were incubated at 37oC for one hour.  The 
restricted plasmid DNA products were analyzed by gel electrophoresis. Samples were 
dyed with 10X DNA dye.  A 1% agarose gel containing ethidium bromide in 1X TAE 
buffer was loaded with the marker Lambda HindIII EcoR1 and the samples.  The gel was 
then run at 100 volts for 45 minutes, and desired products were visualized under UV 
light and photographed. 
Plasmid Vector Cloning with pET-21a 
 One set of Canis lupus familiaris, Capra hircus, Gallus gallus and Monodelphis 
domestica testis derived cDNA was cloned into a plasmid expression vector, pET-21a 
(Novagen).  Nested PCR was utilized in this process as described previously.  Primers 
used are those shown above in Table 3.  The PCR amplified product and the pET-21a 
vector were restricted with EcoR1 and Xho1 endonucleases.  This process was 
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completed with micro-spin columns pre-spun to remove the buffer.  The secondary PCR 
product was spun through the column and then the column was discarded.  Next, 2 µl of 
10X NeBuffer 4 (NEB4) and 0.2 µl of 10mg/ml bovine serum albumin (BSA) was added 
to the tube.  EcoR1 and Xho1 endonucleases were added in volumes of 1µl each and the 
tube was incubated at 37℃ for  three to four hours.   The samples were dyed with 10X 
DNA dye and then analyzed on both 1.0% agarose and an 0.8% LMT agarose gel in 1X 
TAE buffer with Lambda Hindi III EcoR1 as the marker.  The gels were run at 100 volts 
for 45 minutes and visualized under UV light.  Bands of expected size were visualized in 
the 1.0% agarose and thus bands were able to be cut for use in a ligation reaction from 
the 0.8% LMT agarose gel. 
 The expression vector pET-21a was utilized to complete a ligation reactions for 
each species.  Both the cDNA bands cut from the 0.8% LMT agarose gel and the pre-
digested vector were melted at 70ºC for ten minutes before being transferred to a 37ºC 
hold.  Using 8µl of the kit H2O and 2µl 10X ligation buffer for each sample a master mix 
was made on ice.  Each new sample tube was well labeled and placed at 37ºC as well as 
a negative control (NC) tube.  8µl of kit H2O was added to the NC tube and 5µl was 
added to each new sample tube at 37ºC.  Next, 1µl of pET-21a vector was added to each 
tube.  Three micrometers of each cDNA sample was added to its respective new sample 
tube, and the tubes were mixed gently.  Finally, 10µl of the master mix waiting on ice 
was added to each tube and the samples were then incubate at 15ºC overnight.  LB-agar 
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plates for colony growth were not spread with XGAL and IPTG because pET-21a 
contains a lacI region instead of a lacZ region as pCR 2.1 does.  Vector pET-21a also 
demonstrates a higher ampicillin sensitivity and thus specific plates were created for 
each set of samples depending on which vector they were ligated to.  
  The pET-21a clones were purified in the same manner as the pCR2.1 clones 
except they were digested with both EcoR1 and Xho1.  A master mix of 5.8 µl nuclease 
free H2O, 2µl 10X NE Buffer 4 (NEB4), 0.2µl 10mg/ml bovine serum albumin (BSA), 
and 1µl of each restriction endonuclease for each sample was made.  This was then 
combined with 10 µl of the purified plasmid DNA and incubated at 37ºC for three to four 
hours.  Restricted plasmid DNA products were analyzed by gel electrophoresis on a 1% 
agarose gel containing ethidium bromide in 1X TAE buffer with the Lambda HindIII 
EcoR1 marker and desired products were visualized under UV light and photographed. 
DNA Sequencing with PCR 
 Plasmid miniprep samples displaying desired cDNA products in the gel 
photograph of the restriction digests were sequenced with PCR.  This was accomplished 
with Big-Dye mix (Applied Biosystems), nuclease free H2O (Life Technologies, Thermo 
Fisher Scientific, Inc.), M13 forward (5’-TGTAAAACGACGGCCAGT-3’) or reverse 
primer (5’-CAGGAAACAGCTATGAC-3’), and the DNA template from the plasmid 
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miniprep samples selected.  Sequencing of the pET21a clones was completed separately 
with  the T7 promoter primer (5’-TAATACGACTCACTATAG-3’) and the T7 terminator 
primer (5’-GCTAGTTATTGCTCAGCGG-3’).  These were mixed in a  thin-walled PCR 
tube and placed into the PCR machine for 99 cycles of 96oC denaturation for 20 seconds, 
50oC annealing for 10 seconds, and 60oC extension for four minutes. PCR products then 
underwent centrifugation in a mini-spin chromatography tube for the removal of 
unincorporated nucleotides and were submitted for automated sequencing by the Texas 
A&M University Gene Technologies Laboratory.  Samples were denatured at 95ºC and 
sequenced with capillary electrophoresis on an ABI PRISM 3100 Genetic Analyzer.  The 
capillary length was 50 cm and 3130 POP-7 TM polymer was used for sequencing. 
Sequence Analysis 
 Once sequenced the sample nucleotide sequences were retrieved from the Texas 
A&M University Gene Technologies Laboratory website.  The experimentally obtained 
GSTA3 mRNA sequences and chromatograms were then labelled with their miniprep 
number, species, and GSTA3.  The EcoR1 site (GAATTC) of the pCR2.1 vector and the 
“inside” PCR primers were located and marked in the sequence.  The NCBI GenBank 
database records of the human GSTA3 (NM_000847.1) mRNA reference nucleotide 
sequence was used to compare to the experimentally obtained nucleotide sequences from 
other species.  The equine GSTA3 mRNA sequence (KC512384.1) was accessed with 
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this source and used  as a reference for sequence comparisons as well.  Experimentally 
derived sequences were also evaluated for identity to documented GSTA3 genes using 
NCBI’s basic local alignment search tool (BLAST) to check for significant alignments to 
other NCBI reference sequences.   
 The sequence from each species with the highest identity to the NCBI reference 
sequences NM_000847.4 and KC512384.1 was chosen and translated to its amino acid 
sequence.  The antisense sequences chosen were run through the reverse complement 
generator at bioinformatics.org before they were translated.  Translation to the amino 
acid sequence was accomplished by the use of the ExPASy translate tool available 
online.  To ensure that the product sequence was in fact GSTA3 and not one of its very 
similar GSTA family members, the six identified amino acids were located in each 
sequence (Table 1.).  Following this analysis chosen sequences were submitted to NCBI 
GenBank and can be accessed there.  Plasmid maps detailing the restriction sites and 
specific plasmid vectors, as well as sequence orientation and length were also created for 
each GSTA3 sequence submitted (Appendix C, Figures C-1 to C-7). 
Real Time Quantitative Polymerase Chain Reaction 
 Real Time Quantitative Polymerase Chain Reaction (qRT-PCR) was used with 
relative quantification procedures on the RNA samples from multiple tissues in order to 
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quantify concentrations of the GSTA3 mRNA in each of the tissues.  This was 
accomplished through the use of specific qRT-PCR primers designed to generate short 
amplicons of 91 bases. Primers were designed with PrimerExpress (ABI) software 
version 3.0 and ordered from IDT.  Two sets of qRT-PCR primers were used: a set of 
forward and reverse GSTA3 specific primers and a set of forward and reverse GAPDH 
primers (Table 4).  GAPDH mRNA concentrations were measured for possibly 
normalizing the GSTA3 mRNA concentrations.  GAPDH mRNA is commonly used for 
this purpose and is consistent when used in a single tissue.  However, its expression level 
varies across tissues and is generally higher in metabolically active tissues (Sun et al., 
2012).  Pseudogenes which are partially expressed have also been identified for 
GAPDH, which can also cause variation in expression level values obtained from qRT-
PCR (Sun et al., 2012).   Investigators have evaluated possible primer designs which 
would not bind GAPDH pseudogene cDNA and have had no success (Sun et al., 2012). 
!41
Table 4 
Primer sequences used in real time quantitative PCR
Gene Abbr. Sense Antisense
GSTA3 - Eca ACATCCACCTGGTGGAACTTCTCTACCTT CTGGTTTTCAGGGCCTTCAG
GSTA3 - Cfa ACATCCACCTGGTTGAACTTCTCTACT CTGGTTTTCAGGGCCTTCAG
GAPDH - Eca AAGGTCGGAGTAAACGGATTTG CCACTTTGCCAGAGTTAAAAGCA
GAPDH - Cfa AAGGTCGGAGTAAACGGATTTG CCACTTTGCCAGAGTTAAAAGCA
To perform the qRT-PCR reaction, two master mixes were made, one for each set 
of primers.  The master mixes included the forward and reverse primers, Power SYBR 
Green PCR Master Mix (Applied Biosystems), and nuclease free H2O (Life 
Technologies, Thermo Fisher Scientific, Inc.).  The master mixes were pipetted into their 
designated wells in the 96-well qRT-PCR plate and then cDNA from the reverse 
transcriptions were added in triplicates to pre-determined wells. The plate was then 
sealed and placed into the ABI 7900HT Fast Real Time PCR System to run an initial 
denaturation at 95oC for 15 seconds, then 40 cycles of 95oC denaturation for 15 seconds, 
followed by 60oC annealing and extension for one minute.  This was followed by a 20 
minute procedure producing a dissociation curve to assess the melting temperature of the 
amplicons.  Figure 4 displays an example of the amplification and dissociation curves 
which were obtained.  Data resulting from qRT-PCR were then analyzed and utilized in 
the construction of a table displaying the GSTA3 concentration relative to each tissue for 





Figure 4 Example amplification plots and dissociation curves from qRT-PCR of horse  
(Equus caballus) and dog (Canis lupus familiaris) GSTA3 mRNA.  Graphs A and B are 
from horse samples, graph A is the amplification curve and graph B is the dissociation 
curve.  Graphs C and D are from dog, graph C is the amplification curve and graph D is 
the dissociation curve.  
B
Data Analysis 
 Each species yielded mRNA sequences which were then analyzed using multiple 
sequence comparison programs as well as analyzed by hand by comparison of the 
printed sequence to the chromatogram to check for any obvious read errors.  Sequences 
for each species were sorted based on length and quality of the chromatogram and  
primers were located within the sequence.  They were then analyzed with the NCBI 
BLAST nucleotide algorithm to determine their orientation and identity to other known 
sequences.  Those sequences bearing high identity to known glutathione S-transferase 
alpha sequences were then further examined in NCBI BLAST by the use of a multiple  
sequence alignment evaluation of their identity with the reference GSTA3 mRNA 
sequence (NM_000847.1) and the horse GSTA3 previously cloned (KC52384) (Ing et 
al., 2014).   
   The final sequences chosen for each species were then loaded into the Clustal 
Omega multiple sequence alignment program along with both the human and horse 
reference sequences being utilized in this project.  GSTA3 mRNA sequences for each 
species were translated into their amino acid sequences through the use of ExPASy 
translate tool and then compared using the Clustal Omega multiple sequence alignment 
program.  A GSTA3 mRNA sequence for each species was then submitted to NCBI 
GenBank and incorporated into the NCBI database. 
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 The data from the multiple tissues qRT-PCR for specific tissue concentrations 
were analyzed with relative quantification by looking at the amplification plot, the cycle 
threshold (Ct) values. The dissociation curve graphs were examined for homogeneity of 
amplicons from individual gene products.  Ct values were averaged between replicates, 
and the ΔCt and 2-ΔΔCt was also calculated for comparison of mRNA concentrations.  
The data were evaluated with and without normalization to GAPDH mRNA.  The data 
were placed into a table arranged by mRNA concentration values (highest to lowest).  
Values obtained with greater than two fold difference were considered significantly 
different while values with less than two fold difference were considered not 
significantly different and were grouped together.  The value for the lowest GSTA3 
mRNA expressing tissue was set at one, with other tissue values relative to that.  A 




RNA Concentration and Purity 
 Data from the analysis of RNA concentration and purity by Nanodrop 
spectrophotometer demonstrated that each sample was of acceptable purity.  An equal 
volume of each tissue was used for extraction.  All of the samples from testis were of 
similar concentration except for the chicken which had almost double the concentration 
of RNA as the others with 3536.2 ng/µl.  RNA concentrations were high, thus indicative 
of plenty of material to work with.  
Cloned GSTA3 mRNA Sequences 
  Due to high coding sequence identity between the members of the GSTA family, 
a high level of coding sequence identity was required in order to distinguish between 
members of the family.   However, because of the degeneracy of the  genetic code, the 
mRNA sequence did not need to be perfectly identical.  From each species, the mRNA 
sequence which demonstrated the highest identity to the sequences used as reference was 
chosen, and all sequences including the reference sequences were aligned using  the 
Clustal Omega Multiple Sequence Alignment tool.  Output from this alignment is 
displayed in Figure 5.  Percent identity of the GSTA3 mRNAs was determined for each 
species to each of the reference sequences (human NM_000847.4, and horse 
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KC512384), which are 85% identical to each other.  The GSTA3 mRNA sequences from 
dog, goat, opossum and chicken testes displayed 88%, 84%, 70% and 71% identity with 
human GSTA3 mRNA and 87%, 85%, 70% and 69% identity with horse GSTA3 mRNA 
respectively.  These values are arranged in Table 5 for easy comparison.  Coding 
sequences for GSTA3 from each species were deposited in NCBI GenBank.  The 
accession numbers are listed in Table 6. 
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Table 6 
NCBI accession number for cloned GSTA3 cDNAs
Species Accession Number





GSTA3 mRNA percent identities
Human 85% 88% 84% 70% 71%
Horse 87% 85% 70% 69%
Horse Dog Goat Opossum Chicken
Figure 5 Aligned nucleotide sequences of the coding sequences of GSTA3 mRNAs from selected species 
including those used as reference. Human (Homo sapiens; NM_000847.4), horse (Equus caballus; 
KC512384.1), dog (Canis lupus familiaris; KJ651954), goat (Capra hircus; KM578828), opossum 
(Monodelphis domestica; KM977823), chicken (Gallus gallus; KP686393) are those displayed here.  Dog, 
goat, opossum and chicken cDNA sequences were cloned in the current study.  Shared identities with the 
human reference sequence were highlighted in gray.  Start and stop codons are identified in bold, green 
and red type, respectively, and codons for the amino acids critical to the GSTA3 enzyme’s isomerase 
activity have been identified in bold, multicolored type. 
Human      ATGGCAGGGAAGCCCAAGCTTCACTACTTCAATGGACGGGGCAGAATGGAGCCCATCCGG
Horse      ATGGCAGTGAAGCCCATGCTTCACTACTTCAATGGACGAGGCCGGATGGAGCCTATCCGG
Dog        ATGGCGGGGAAGCCCAAGCTTCACTACTTCAATGGACGAGGCAGAATGGAGTCCATCCGG
Goat       ATGGCAGGGAAGCCCATTCTTCACTATTTCAATGGACGCGGCAGAATGGAGTGCATTCGG
Possum     ATGGCAGTGAAGCCCATGCTTCACTACTTCAATGGAAGAGGCAGAATGGAATCAGTGCGC
Chicken    ATGTCGGGGAAGCCCAGGCTCACCTATGTCAATGGGAGAGGGCGAATGGAGTCCATCCGA
           *** * * ********  **   ***  *******  * **  * *****     * ** 
Human      TGGCTCTTGGCTGCAGCTGGAGTGGAGTTTGAAGAGAAATTTATAGGATCTGCAGAAGAT
Horse      TGGCTCCTGGCTGCTGCGGGAGTCGAGTTTGAAGAGACATTTATAGACACTCCAGAAGAC
Dog        TGGCTCCTGGCTTCAGCTGGAGTAGAGTTTGAAGAGAAATTTATAAATACTCCAGAAGAC
Goat       TGGCTCCTGGCTGCGGCTGGAGTGGAGTTTGAAGAAAAATTTATAGAAAAACCAGAAGGC
Possum     TGGCTCTTGGCAGCTGCTGGAGTCGAGTTTGAAGAAAAGATATTAAAATCAGCTGAAGAT
Chicken    TGGCTGCTGTCCGCAGCTGGAGTGGAGTTTGAAGAAATTTTTCTGGAAACAAGAGAGCAG
           *****  ** *  * ** ***** *********** *   *  *          **    
Human      TTGGGAAAGTTAAGAAATGATGGGAGTTTGATGTTCCAGCAAGTACCAATGGTTGAGATT
Horse      TTTGAAAAGCTAAAAAATGATGGGAGTTTGATGTTCCAGCAAGTGCCAATGGTCGAAATT
Dog        TTGGATAAATTAAAAAATGATGGAAGTCTGATGTTCCAGCAAGTGCCAATGGTGGAAATT
Goat       TTGGATAAGTTAAAAAATGATGGGAGTTTGATGTTCCAGCAAGTGCCAATGGCTGAAATT
Possum     TTTGAAAATTTAGTTAAGGGTGGAAACCTGATGTATCAACAAGTGCCAATGGTTGAAATT
Chicken    TTATTGAAGTTATGCCAAGATGGATCCCTGCTGTTCCACCAACTGCCACTGGTTGAGATC
           **    **  **    * * ***     ** ***  ** *** * *** ***  ** ** 
Human      GATGGGATGAAGTTGGTACAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
Horse      GATGGGATGAAGCTGGTGCAGAGCAGAGCCATTCTCAACTATGTTGCCGCCAAACACAAC
Dog        GATGGAATGAAGCTGGTACAGGCCAGAGCCATTCTCAACTACATTGCCACCAAATACAAC
Goat       GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATTGCCGCCAAACACAAC
Possum     GATGGACTGAACCTGGTACAAACCAGAGCCATCCTGAAGTATATAGCTGCCAAATACAAC
Chicken    GACGGGATGAAGTTGGTGCAGTGCAGAGCCATCCTCAGCTACATCGCAGGGAAATACAAT
           ** **  ****  **** **   ********* ** *  **  * **    *** **** 
Human      CTCTACGGGAAAGACATAAAGGAGAGAGCCCTAATTGATATGTATACAGAAGGTATGGCA
Horse      CTCTATGGGAAAGACATCAAGGAGAGAGCCCTGATTGATATGTACATAGAAGGTGTGGCA
Dog        CTCTATGGGAAAGACATAAAGGAGAGAGCTCTGATAGATATGTACACAGAAGGTATAGTA
Goat       CTCTACGGGAAAGACATGAAGGAGAGAGCCCTGATTGATATGTACTCAGAGGGTGTGGCA
Possum     TTGTATGGGAAGGACCTGAAGGAGAAAGCTCTGATTGACATGTATGTGGAAGGGATGAGA
Chicken    CTCTATGGGAAAGACCTGAAGGAGAGAGCCCTGATCGACATGTATGTGGAAGGAATATCA
            * ** ***** *** * ******* *** ** ** ** *****    ** **  *   *
Human      GATTTGAATGAAATGATCCTTCTTCTGCCCTTATGTCGACCTGAGGAAAAAGATGCCAAG
Horse      GATTTGAATGAAATGATCCTGCTTTTACCCATAACCCCACCTGCTGAAAAAGATGCTAAG
Dog        GATTTGAATGAAATGATCATGGTTTTGCCTCTATGCCCACCTGATCAAAAAGATGCCAAG
Goat       GATTTGGGTGAAATGATCATGCATTTGCCACTGTGCCCACCTGCTGAAAAAGACGCCAAG
Possum     GATCTGAATGAAATGATCATGTACTACCCACTGTGTTATCCTGGAGAAGAGGAAAAGAAC
Chicken    GACCTGATGCAATTGATTTTGGTGTTTCCTTTCTCTCCACCTGCGGCAAAGGAGGAAAAT
           **  **    ** ****  *       **  *       ****    * * **    ** 
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Figure 5 Continued 
Human      ATTGCCTTGATCAAAGAGAAAACAAAAAGTCGCTATTTCCCTGCCTTCGAAAAAGTGTTA
Horse      ATTATGCTGATCAAAGACAGAACAACAAATCGTTATTTGCCTGCGTTTGAAAAAGTGTTA
Dog        ATTACTCTGATCAGAGAGAGAACAACAGATCGTTATCTCCCCGTGTTTGAAAAAGTGTTA
Goat       CTGACCCTAATCCGAGAAAAGACAACAAACCGTTATCTCCCTGCATTTGAAAATGTGCTG
Possum     CTCAACTTCATCCTGGAGAGAGCCACTGAAAGATTCTTCCCAGTGTATGAGAAGGCTTTA
Chicken    CTTGCCACAATTGCAGAGAAGGCAACAGAGAGGTACTTCCCTGTCTTTGAAAAGGTTTTG
            *       **    ** *   * *      * *   * ** *  *  ** ** *   * 
Human      CAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTAGCCTG
Horse      AAGAGCCACGGAGAAGACTATCTGGTTGGAAACAGGCTGAGCAGGGCTGACATCCACCTG
Dog        AAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCAGGGCTGACATTCACCTG
Goat       AAGAGCCACGGACAAGACTACCTGGTGGGCAACAAGCTGAGCAGGGCTGACATCCACCTG
Possum     AAAAGTCATGGGAAAAATTATCTTGTTGGCAACCAGATGAGCTGGGCAGATATACAGCTG
Chicken    AAACAGCATGGCCAAGACTTTCTTGTGGGAAACCGATTCAGCTGGGCAGATGTTCAGCTC
            *    ** **  ** * *  ** ** ** ***    * *** **** **  *    ** 
Human      GTGGAACTTCTCTACTATGTGGAAGAGCTTGACTCCAGCCTTATCTCCAACTTCCCTCTG
Horse      GTGGAACTTCTCTACCTTGTTGAAGAGCTTGACCCCAGCCTTCTGACCAACTTCCCTCTG
Dog        GTTGAACTTCTCTACTATGTGGAAGAGCTTGACTCCAGCCTTCTGGCCAACTTCCCTCTG
Goat       GTTGAACTTCTCTACTATGTGGAAGAGCTGGACCCTAGCCTTTTGGCCAGCTTCCCTCTG
Possum     TTTGAAGCCATCCTAATGGTTGAAGAATTAAAGTCGGATATTCTCTCTGCATTCCCTAAA
Chicken    ATGGAAGCCATTTTAGCAGTGGAGGAGAAAGTGCCTTCTGTGCTTTCTGGGTTTCCTCAG
            * ***    *       ** ** **        *     *  *  *    ** ***   
Human      CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACGGTGAAGAAGTTTCTACAGCCT
Horse      CTGAAGGCCCTGAAAGCCAGAATCAGCAACCTGCCCACCGTGAAGAAGTTTCTGCAGCCT
Dog        CTGAAGGCCCTGAAAACCAGAGTCAGCAATCTCCCCACCGTGAAGAAGTTTCTGCAGCCT
Goat       CTGAAGGCCCTAAAAGCCAGAGTCAGCAATCTCCCGGCCGTGAAGAAGTTTCTGCAGCCC
Possum     CTGCAGGAGTTCAAAGCTAGAATGAGCAAACTCCCCAGCATTCAGAAATTCCTTCAGCCT
Chicken    CTGCAGGCTTTTAAAACCAAAATGAGCAACATGCCTACAATTAAGAAGTTCCTGCAGCCT
           *** ***   * *** * * * * *****  * **     *  **** ** ** ***** 
Human      GGCAGCCCAAGGAAGCCTCCCGCAGATGCAAAAGCTTTAGAAGAAGCCAGAAAGATTTTC
Horse      GGTGGGGCGAGGAAGCCTCCAGGGGATGAGAAATCTGTAGAAAAGTCAAGGAAGATTTTC
Dog        GGCAGCCCAAGGAAGCCTCCCTTGGATGAGAAAAGTTTAGAGCAAGCGAAGAAGATTTTC
Goat       GGTAGCCAGAGGAAGCCTCCCACGGACGAGAAAAAAATAGAAGAAGCCAGGAGGGCTTTC
Possum     GGCAGTCAAAGAAAAGCAAAAATGGATGGCAAAAATCTTGCAGAGGCAAAGAAGATATTC
Chicken    GGCAGCCCAAGGAAGCCCCCACCAGATGAACATTATGTAGCAACTGTGAAGAAAATTTTT
           **  *    ** **  *       ** *   *     * *        *  *     ** 
Human      AGGTTTTAA---
Horse      AAGTTTTGA---
Dog        AGGATTAACTGA
Goat       AAGTTTTAA---
Possum     AAGTTTGAATGA
Chicken    AAGCTAAACTGA
           * * *
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 Cloned GSTA3 protein sequences demonstrated an extremely high degree of 
identity. The six critical amino acids for 3-ketosteroid isomerase activity of GSTA3 as 
identified by Dourado et al. (2014), Johansson and Mannervik (2002), and Petterson et 
al. (2002) which were displayed in Table 1, were located in each sequence.  The protein 
alignment of GSTA3 protein displayed in Figure 6 has the six critical amino acids for 3-
ketosteroid isomerase activity highlighted. Percent positives were calculated instead of 
percent identities for each of the cloned GSTA3 protein sequences to the sequences used 
as reference.  This method was used in order to account for conservative substitutions 
due to similar chemical properties of an amino acid residue.  Results from these 
calculations  displayed 92%, 88%, 77% and 77% positive identity with human GSTA3 
protein and 90%, 90%, 77% and 78% positive association with horse GSTA3 protein for 
the dog, goat, chicken and opossum respectively.  The reference human and horse 
GSTA3 protein sequences demonstrated 90% positive identities when compared to each 
other.   These values are arranged in Table 7.  No significant dissimilarities were 
observed in the locations of the critical amino acids for the GSTA3 enzyme’s 3-
ketosteroid isomerase activity.  
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Table 7 
GSTA3 protein percent positive identities
Human 90% 92% 88% 77% 77%
Horse 90% 90% 77% 78%
Horse Dog Goat Opossum Chicken
!51
Figure 6 Aligned amino acid sequences for GSTA3 of all species investigated including those 
used as reference.  The critical amino acids for 3-ketosteroid isomerase activity are highlighted.  
Symbols: *= identical residues, : = similar residues, . = conservation of groups with weakly 
similar properties 
Human        MAGKPKLHYFNGRGRMEPIRWLLAAAGVEFEEKFIGSAEDLGKLRNDGSLMFQQVPMVEI
Horse        MAVKPMLHYFNGRGRMEPIRWLLAAAGVEFEETFIDTPEDFEKLKNDGSLMFQQVPMVEI
Dog          MAGKPKLHYFNGRGRMESIRWLLASAGVEFEEKFINTPEDLDKLKNDGSLMFQQVPMVEI
Goat         MAGKPILHYFNGRGRMECIRWLLAAAGVEFEEKFIEKPEGLDKLKNDGSLMFQQVPMAEI
Opossum      MAVKPMLHYFNGRGRMESVRWLLAAAGVEFEEKILKSAEDFENLVKGGNLMYQQVPMVEI
Chicken      MSGKPRLTYVNGRGRMESIRWLLSAAGVEFEEIFLETREQLLKLCQDGSLLFHQLPLVEI
             *: ** * *.******* :****::******* :: . * : :* : *.*:::*:*:.**
Human        DGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYTEGMADLNEMILLLPLCRPEEKDAK
Horse        DGMKLVQSRAILNYVAAKHNLYGKDIKERALIDMYIEGVADLNEMILLLPITPPAEKDAK
Dog          DGMKLVQARAILNYIATKYNLYGKDIKERALIDMYTEGIVDLNEMIMVLPLCPPDQKDAK
Goat         DGMKLVQTRAILNYIAAKHNLYGKDMKERALIDMYSEGVADLGEMIMHLPLCPPAEKDAK
Opossum      DGLNLVQTRAILKYIAAKYNLYGKDLKEKALIDMYVEGMRDLNEMIMYYPLCYPGEEEKN
Chicken      DGMKLVQCRAILSYIAGKYNLYGKDLKERALIDMYVEGISDLMQLILVFPFSPPAAKEEN
             **::*** ****.*:* *:******:**:****** **: ** ::*:  *:  *  :: :
Human        IALIKEKTKSRYFPAFEKVLQSHGQDYLVGNKLSRADISLVELLYYVEELDSSLISNFPL
Horse        IMLIKDRTTNRYLPAFEKVLKSHGEDYLVGNRLSRADIHLVELLYLVEELDPSLLTNFPL
Dog          ITLIRERTTDRYLPVFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLLANFPL
Goat         LTLIREKTTNRYLPAFENVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDPSLLASFPL
Opossum      LNFILERATERFFPVYEKALKSHGKNYLVGNQMSWADIQLFEAILMVEELKSDILSAFPK
Chicken      LATIAEKATERYFPVFEKVLKQHGQDFLVGNRFSWADVQLMEAILAVEEKVPSVLSGFPQ
             :  * :::..*::*.:*:.*:.**:::****::* **: *.* :  ***   .::: ** 
Human        LKALKTRISNLPTVKKFLQPGSPRKPPADAKALEEARKIFRF-
Horse        LKALKARISNLPTVKKFLQPGGARKPPGDEKSVEKSRKIFKF-
Dog          LKALKTRVSNLPTVKKFLQPGSPRKPPLDEKSLEQAKKIFRIN
Goat         LKALKARVSNLPAVKKFLQPGSQRKPPTDEKKIEEARRAFKF-
Opossum      LQEFKARMSKLPSIQKFLQPGSQRKAKMDGKNLAEAKKIFKFE
Chicken      LQAFKTKMSNMPTIKKFLQPGSPRKPPPDEHYVATVKKIFKLN
             *: :*:::*::*:::******. **   * : :   :: *:: 
Multiple Tissues GSTA3 mRNA Concentrations 
 Triplicates of each tissue sample were run for both GAPDH and GSTA3.  
Calculations for relative quantification (2-ΔΔCt ) were completed.  The normalized and 
non-normalized GSTA3 mRNA values of the lowest expressing tissue were then set to 
one with other tissue values relative to that.  Tissues were ranked according to GSTA3 
concentration.  These values were then utilized to construct tables to easily demonstrate 
which tissues had a higher concentration of the GSTA3 gene.  Tissues with more than a 
four-fold change in concentration were separated by a V to allow quick visual distinction 
and the tissue with the highest concentration of GSTA3 is listed at the top.  Data for 
GSTA3 mRNA expression levels are displayed below in Tables 8 and 9 and the GSTA3 
mRNA expression levels normalized to GAPDH mRNA expression can be found in 
Appendix D, Tables A-1 and A-2.  Normalized data were placed in the appendix due to 
the variability of GAPDH mRNA expression across tissues and the possible effects of 
this on the normalized GSTA3 mRNA expression values.   
 The samples from Equus caballus which demonstrated the greatest GSTA3 
mRNA concentrations were testes and the adrenal glands.  These results were as 
expected.  Much of the literature describes the highest expression of the GSTA3 gene as 
localized in steroidogenic tissues.  Samples from horse liver demonstrated intermediate 
levels of GSTA3 mRNA expression.  Tissues with extremely low concentrations 
included the cerebrum, skeletal muscle, heart and mammary.  Some samples from this 
experiment were sequenced and verified as GSTA3 mRNA.      
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 GSTA3 mRNA levels were analyzed in Canis lupus familiaris tissue samples.  
Dog cerebrum, skeletal muscle, heart, mammary gland, uterus kidney and hypothalamus 
had the lowest concentrations of GSTA3 mRNAs.  Although the testes demonstrated 
high concentrations of  the GSTA3 gene, the liver demonstrated the highest 
concentrations, with concentrations in the adrenal glands and small intestine slightly 
lower.  Due to the role of the GSTAs as detoxification enzymes this finding was not 
surprising.  GSTA3’s main role is as a steroid isomerase, but it still retains its 
detoxification activity.  Other studies have observed high expression levels of GSTA3 
mRNA in these tissues as well (Gropp et al., 2006).  It is also possible that the primers 
used did not selectively bind GSTA3 mRNA and that GSTA1 mRNA expression levels is 
represented in the data as well.   The sense primer used had two mismatches with the 
GSTA1 mRNA sequence and the antisense primer had one mismatch.  One mismatch 
from each primer was located at the 3’ end which should have allowed for selective 
binding.  These mismatches are displayed in Figure 7.   The dogs from which the tissues 
were obtained were research animals and were fairly old (7 to 12 years of age).  
Continued investigation is warranted to provide further support for this data.  
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Table 8   
GSTA3 mRNA levels in equine tissues measured by real time quantitative polymerase 
chain reaction.  The lowest value was set to one with all other values relative to that in 
order to rank the tissues based on their concentrations. “V” designates a 4 fold or more 
difference between tissue values.  A table displaying the ranking after normalization to 
GAPDH mRNA expression is not shown due to the high variability of GAPDH 
mRNA expression across tissues but has been included in Appendix D, Table D-1.




Small Intestine (90), Ovary (70), Kidney Cortex (50), Hypothalamus (40)
V
Uterus (9), Urinary Bladder, Spleen (7), Lung, Skeletal Muscle (4)
V
Heart, Mammary (2), Cerebrum (1)
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Table 9   
GSTA3 mRNA levels in canine tissues measured by real time quantitative polymerase 
chain reaction.  The lowest value was set to one with all other values relative to that in 
order to rank the tissues based on their concentrations. “V” designates a 4 fold or more 
difference between tissue values.  A table displaying the ranking after normalization to 
GAPDH mRNA expression is not shown due to the high variability of GAPDH 
mRNA expression across tissues but has been included in Appendix D, Table D-2.
Liver (4762)
V
Testes (754), Small Intestine (556)
V




Heart (18), Ovary 2 (17)
V
Mammary (9), Cerebrum (8)
Kidney (6), Hypothalamus (4)
V
Uterus (1)
Figure 7 Double stranded DNA sequences of the putative amplicons of GSTA1 and GSTA3 with 
primer binding sites for primers used in qRT-PCR highlighted to demonstrate the primers’ 
specificity for GSTA3.  Asterisks denote an exact match of the primer to the DNA sequence.   
Horse GSTA1 (NM_001284532) with GSTA3 qRT-PCR primers: 
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TGAAAGGAGACCACTTCCGGGACTTTTGGTC        
                             ******************* 










 The coding sequence of the Glutathione S-transferase alpha 3 mRNA is well 
conserved across species including those of a divergent nature.  The highest observed 
concentrations are localized to tissues involved in steroidogenesis and detoxification as 
was expected based on previously published literature and the known chemical functions 
of the GSTA family of enzymes.  These results provide further support for the research 
demonstrating the greater activity of the GSTA3 enzyme to that of the HSD3B2 enzyme 
as a 3-ketosteroid isomerase in the △5 testosterone production pathway and to the need 
for precisely chosen research animals when modeling a specific system or pathway.  
Also, this knowledge provides building blocks to fully elucidating the mechanisms 
behind steroidogenesis which will provide the ability for important advances in the 
medical research relating to numerous diseases and treatments.  However, theres still a 
need for further elucidation of the mechanisms of regulation behind the actions of the 
GSTA3 enzyme.   
Steroidogenesis  
 Matsumura and colleagues (2013) have taken on the question of regulation of the 
GSTA3 gene and have demonstrated regulation of the GSTA family by the actions of 
steroidogenic factor 1 (SF-1) which is a nuclear orphan receptor and a master regulator 
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for steroidogenesis (Parker and Schimmer, 1997).  This study revealed through the use of 
a chromatin immunoprecipitation assay (ChIP) that SF-1 binds directly to the promoter 
of the GSTA3 gene and thus up regulates transcription (Matsumura et al., 2013).  SF-1 
has also been linked to tissue specific expression of genes involved in steroid hormone 
biosynthesis and, when knocked out in mice, failure of adrenal and gonadal development 
and impaired gonadotrope function were observed (Parker and Schimmer, 1997).  
Normal development of the reproductive system and sex hormone production is required 
for fertility.  A clear link between reduced fertility/sex hormone production levels and 
stress has also been defined by other researchers.   Many studies have utilized 
glucocorticoids to research the physiological effects of stress, and  have documented 
glucocorticoid concentration changes during different events ranging from trailering of 
horses (Schmidt et al., 2010), scrotal insulation and dexamethasone treatment in bulls 
(Barth and Bowman, 1994) to aging and obesity in humans (Blouin et al., 2006; Chung 
et al., 2001; Wang and Stocco, 2005), as well as a number of other conditions (Cooke et 
al., 1991; Cornelisse et al., 2004; Danek, 2004; Gold et al., 2012; Grady et al., 2010; 
Haffner et al., 2009; Hardy et al., 2005; Ing et al., 2014, 2015; Kizaki et al., 1998; Liu et 
al., 2011; Lopez-Calderon et al., 1991; Quax et al., 2013). 
 Kizaki and colleagues (1998) demonstrated significant age related increases in 
glucocorticoid production in mice.  They hypothesized that this is a consequence of 
progressive dysfunction of the hypothalmic-pituitary-adrenal axis.  As these changes 
occur there is a corresponding decrease in testosterone production which contributes to 
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the hypothesis that glucocorticoids have a role in regulating steroidogenesis.  This 
hypothesis is supported by the presence of glucocorticoid receptors in the Leydig cells as 
well as the demonstration of apoptosis in Leydig cells in rats and horses after 
corticosterone administration (Payne and Youngblood, 1995; Yoon and Roser, 2010). 
The Leydig cell is the most efficient cell in the male at using cholesterol to synthesize 
testosterone and sufficient numbers of functional Leydig cells is required to maintain the 
necessary levels of testosterone production (Payne and Youngblood, 1995).  Adequate 
testosterone production is required for normal male sexual differentiation and fetal 
development as well as the initiation and maintenance of spermatogenesis and 
expression of male secondary sex characteristics (Payne and Youngblood, 1995).   
 Age related changes have been documented in relation to Sertoli cell, Leydig 
cell, testosterone concentration and sperm production.  In the horse specifically, puberty 
begins at one to one and a half years of age, and adult numbers of Leydig cell, Sertoli 
cell and sperm production are reached by age four (Sipahutar et al., 2003). The stallion 
demonstrates heterogeneity in composition due to light and dark Leydig cell populations, 
a characteristic shared with the rat which demonstrates a commonality between 
mammalian species (Sipahutar et al., 2003)  This is hypothesized to be related to 
different steroidogenic capacities in the two Leydig cell types (Sipahutar et al., 2003).  
Leydig cell aging is a popular region of study due to its immense impact on hormone 
balance and thus on long term health and disease risk factors.  The ability to induce a 
steroidogenic dormant period by which aging of Leydig cells is halted was demonstrated 
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by Chen and Zirkin (1999).  In this study rats were given Silastic implants which 
delivered sustained release testosterone and halted endogenous production.  After eight 
months the implants were removed and two months later testosterone production levels 
were compared between the treatments and controls identifying a significant decrease in 
control rats (Chen and Zirkin, 1999).  The authors postulated a delay in Leydig cell 
aging and the subsequent reduction in testosterone and its related adverse health 
consequences as an application of these findings with the use of male contraceptives.  
The mechanisms by which this outcome occurred and the unobserved effects on the 
production other components of the testosterone biosynthesis such as HSD3B2 and 
GSTA3 must first be investigated. 
Glutathione S-transferase Alpha 3 
 In this project the active site residues proposed by Johansson and Mannervik 
(2002) and Dourado et al. (2014) for glutathione S-transferase alpha 3’s isomerase 
activity were located in the amino acid sequences of multiple species including divergent 
species Monodelphis domestica and Gallus gallus.  This demonstrates the conservation 
of the enzyme in species which utilize the △5 steroidogenic pathway.  In 2002 
Johansson and Mannervik reported a mechanism for the isomerase activity. More 
recently, Calvaresi and colleagues (2012) performed an investigation into the catalytic 
activity of the GSTA3 enzyme.  This team of researchers utilized Quantum Mechanics/
Molecular Mechanics to computationally elucidate the catalytic mechanisms behind the 
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isomerase activity of human GSTA3.  Their research not only validated Johansson and 
Mannervik’s (2002) hypothesis that the GSH cofactor acts as an acid/base catalyst, but 
also provided a detailed description of the mechanism behind the isomerization reaction.  
The reaction was originally thought to be a two-step process but was shown to be 
concerted, highly asynchronous and fully dependent on the contributions of the active 
site residues outlined by other authors (Calvaresi et al, 2012; Dourado et al., 2014; 
Johannson and Mannervik, 2002; Petterson et al., 2002).  These findings are 
corroborative to the mRNA sequences of GSTA3 obtained in this study and its 
importance in the △5 testosterone biosynthesis pathway. 
 There are many species which utilize the △5 testosterone biosynthesis pathway 
in which the presence of GSTA3 is still unverified.  Elucidation of specific species 
which employ this enzyme is intrinsic to fully comprehending the mechanisms behind 
testosterone biosynthesis and reproductive function for species like humans and 
livestock in which research is not always an option.  The mouse is the current most 
popular organism for this purpose, however, rodents utilize the △4 pathway of 
steroidogenesis. For a complete understanding of the △5 testosterone biosynthesis 
pathway and maximum application of this knowledge, steroidogenesis should be 
investigated in many species, including those of a divergent nature.  
 Continued research into GSTA3 gene products and the effects of glucocorticoids 
will further demonstrate the regulatory mechanisms which alter testosterone 
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concentrations and thus impact fertility and possibly over-all health of an individual.  
Due to the ever increasing genetic information the identification of species which utilize 
GSTA3 and the △5 testosterone production pathway should be an easier task than it was 
previously.   The availability of completed genomes in databases like NCBI will allow 
for many species to be identified before confirming the genes presence experimentally, 
thus saving time and money.  Execution of a large cross-species comparison study on the 
regulation of the GSTA3 gene would yield valuable data with high applicability to the 





 The glutathione S-transferase alpha 3 mRNA sequence is well conserved across 
species which utilize the △5 testosterone biosynthesis pathway and is most highly 
expressed in steroidogenic tissues.  This study has demonstrated this conservation occurs 
not only in closely related species but also across divergent species.  Conservation of this 
gene across such a broad range of species is indicative of its importance in 
steroidogenesis.  It is crucial that a complete understanding of steroidogenesis is 
developed considering the numerous steroid hormone-dependent diseases and endocrine 
disorders need novel treatments.  As a recently discovered enzyme, GSTA3 requires 
extensive analysis to fully identify its mechanisms of action in the △5 testosterone 
biosynthesis pathway. 
  Expression of the pET-21a clones and evaluation of their steroid isomerase 
activity will also provide useful information for designing future experiments.   The 
pET-21a expression vector utilizes bacteriophage T7 transcription and expression is 
induced by T7 RNA polymerase (Novagen, 2003).  When fully induced, T7 RNA 
polymerase can convert most of the cell’s resources to target gene expression and within 
a few hours the desired product can constitute more than 50% of the total cell protein 
(Novagen, 2003).  The pET-21a expression vector also contains a multiple cloning 
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region which contains unique restriction sites in order to utilize directional cloning of the 
target sequence (Novagen, 2003).  This will increase the number of clones capable of 
expression.  Proteins expressed by the pET-21a vector do not contain vector encoded 
sequences (Novagen, 2003).  The construction of this system allows for the efficient 
production of large amounts of native protein and quick purification.   
 Expression and analysis of the GSTA3-pET-21a clones generated during this 
experiment will produce quantitative comparisons of the steroid isomerase activity of the 
GSTA3 enzyme between the species investigated.  Many regulators of the GSTA3 gene 
have been identified.  The availability of expressed GSTA3-pET-21a clones will allow 
for further investigation of the effects of endogenous compounds like FSH, testosterone, 
estradiol and glucocorticoids, as well as pharmaceuticals like phenobarbital and 
dexamethasone on the expression of the GSTA3 enzyme.  Insights into those compounds 
which regulate the GSTA3 enzyme can impart medically relevant advances in treating 
androgen and estrogen dependent diseases.  Considering the value and distribution of 
pharmaceuticals utilized in the treatment of diseases like prostate cancer, breast cancer, 
polycystic ovary syndrome, and infertility, it is essential that the treatments that are 
prescribed are both specific and effective.  
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Human GSTA mRNA Alignment 
Figure A-1 Aligned nucleotide sequences of the coding sequences of GSTA mRNAs 
from humans only. Human (Homo sapiens) GSTA3 (NM_000847.4), GSTA1 
(NM_145740.3), GSTA2 (NM_000846.4), and GSTA5 (NM_153699.1) with highlighted 
regions of identity to GSTA3.  
hGSTA3    ATGGCAGGGAAGCCCAAGCTTCACTACTTCAATGGACGGGGCAGAATGGAGCCCATCCGG
hGSTA1    ATGGCAGAGAAGCCCAAGCTCCACTACTTCAATGCACGGGGCAGAATGGAGTCCACCCGG
hGSTA2    ATGGCAGAGAAGCCCAAGCTCCACTACTCCAATATACGGGGCAGAATGGAGTCCATCCGG
hGSTA5    ATGGCAGAGAAGCCCAAGCTCCACTACTCCAATGCACGGGGCAGTATGGAGTCCATTCGG
******* ************ ******* ****  ********* ****** ***  ***
hGSTA3    TGGCTCTTGGCTGCAGCTGGAGTGGAGTTTGAAGAGAAATTTATAGGATCTGCAGAAGAT
hGSTA1    TGGCTCCTGGCTGCAGCTGGAGTAGAGTTTGAAGAGAAATTTATAAAATCTGCAGAAGAT
hGSTA2    TGGCTCCTGGCTGCAGCTGGAGTAGAGTTTGAAGAGAAATTTATAAAATCTGCAGAAGAT
hGSTA5    TGGCTCCTGGCTGCAGCTGGAGTAGAGTTGGAAGAGAAATTTCTAGAATCTGCAGAAGAT
****** **************** ***** ************ **  *************
hGSTA3    TTGGGAAAGTTAAGAAATGATGGGAGTTTGATGTTCCAGCAAGTACCAATGGTTGAGATT
hGSTA1    TTGGACAAGTTAAGAAATGATGGATATTTGATGTTCCAGCAAGTGCCAATGGTTGAGATT
hGSTA2    TTGGACAAGTTAAGAAATGATGGATATTTGATGTTCCAGCAAGTGCCAATGGTTGAGATT
hGSTA5    TTGGACAAGTTAAGAAATGATGGGAGTTTGCTGTTCCAGCAAGTACCAATGGTTGAGATT
****  *****************   **** ************* ***************
hGSTA3    GATGGGATGAAGTTGGTACAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
hGSTA1    GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
hGSTA2    GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
hGSTA5    GACGGGATGAAGCTGGTGCAGACCAGAGCCATTCTTAACTACATTGCCAGCAAATACAAC
** ********* **** ***************** ************************
hGSTA3    CTCTACGGGAAAGACATAAAGGAGAGAGCCCTAATTGATATGTATACAGAAGGTATGGCA
hGSTA1    CTCTATGGGAAAGACATAAAGGAGAGAGCCCTGATTGATATGTATATAGAAGGTATAGCA
hGSTA2    CTCTATGGGAAAGACATAAAGGAGAAAGCCCTGATTGATATGTATATAGAAGGTATAGCA
hGSTA5    CTTTATGGGAAAGACATGAAGGAGAGAGCCCTGATTGATATGTACACAGAAGGTATAGTA
** ** *********** ******* ****** *********** * ********* * *
hGSTA3    GATTTGAATGAAATGATCCTTCTTCTGCCCTTATGTCGACCTGAGGAAAAAGATGCCAAG
hGSTA1    GATTTGGGTGAAATGATCCTCCTTCTGCCCGTATGTCCACCTGAGGAAAAAGATGCCAAG
hGSTA2    GATTTGGGTGAAATGATCCTTCTTCTGCCCTTTAGTCAACCTGAGGAACAAGATGCCAAG
hGSTA5    GATTTGACTGAAATGATCCTTCTTCTGCTCATATGTCAACCAGAGGAAAGAGATGCCAAG
******  ************ ******* * *  *** *** ******  **********
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Figure A-1 Continued 
hGSTA3    ATTGCCTTGATCAAAGAGAAAACAAAAAGTCGCTATTTCCCTGCCTTCGAAAAAGTGTTA
hGSTA1    CTTGCCTTGATCAAAGAGAAAATAAAAAATCGCTACTTCCCTGCCTTTGAAAAAGTCTTA
hGSTA2    CTTGCCTTGATCCAAGAGAAAACAAAAAATCGCTACTTCCCTGCCTTTGAAAAAGTCTTA
hGSTA5    ACTGCCTTGGTCAAAGAGAAAATAAAAAATCGCTACTTCCCTGCCTTTGAAAAAGTCTTA
******* ** ********* ***** ****** *********** ******** ***
hGSTA3    CAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTAGCCTG
hGSTA1    AAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTCATCTG
hGSTA2    AAGAGCCACGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTCACCTG
hGSTA5    AAGAGCCACAGACAAGACTACCTTGTTGGCAACAAGCTGAGCTGGGCTGACATTCACCTG
*******  ******************************** ***********   ***
hGSTA3    GTGGAACTTCTCTACTATGTGGAAGAGCTTGACTCCAGCCTTATCTCCAACTTCCCTCTG
hGSTA1    GTGGAACTTCTCTACTACGTCGAGGAGCTTGACTCCAGTCTTATCTCCAGCTTCCCTCTG
hGSTA2    GTGGAACTTCTCTACTACGTGGAAGAGCTTGACTCTAGCCTTATTTCCAGCTTCCCTCTG
hGSTA5    GTGGAACTTTTCTACTACGTGGAAGAGCTTGACTCGAGTCTTATCTCCAGCTTCCCTCTG
********* ******* ** ** *********** ** ***** **** **********
hGSTA3    CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACGGTGAAGAAGTTTCTACAGCCT
hGSTA1    CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACAGTGAAGAAGTTTCTACAGCCT
hGSTA2    CTGAAGGCCCTGAAAACCAGAATCAGTAACCTGCCCACAGTGAAGAAGTTTCTACAGCCT
hGSTA5    CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACGGTGAAGAAGTTTCTGCAGCCT
************************** *********** ************** ******
hGSTA3    GGCAGCCCAAGGAAGCCTCCCGCAGATGCAAAAGCTTTAGAAGAAGCCAGAAAGATTTTC
hGSTA1    GGCAGCCCAAGGAAGCCTCCCATGGATGAGAAATCTTTAGAAGAAGCAAGGAAGATTTTC
hGSTA2    GGCAGCCCAAGGAAGCCTCCCATGGATGAGAAATCTTTAGAAGAATCAAGGAAGATTTTC
hGSTA5    GGCAGCCAGAGAAAGCCTCCCATGGATGAGAAATCTTTAGAAGAAGCAAGGAAGATTTTC
*******  ** *********   ****  *** *********** * ** *********
hGSTA3    AGGTTTTAA
hGSTA1    AGGTTTTAA
hGSTA2    AGGTTTTAA




Placental Mammals GSTA3 mRNA Alignment 
Figure B-1 Aligned nucleotide sequences of the coding sequences of GSTA3 mRNAs 
from placental species only including those used as reference. Human (Homo sapiens; 
NM_000847.4), horse (Equus caballus; KC512384.1), dog (Canis lupus familiaris; 
KJ651954), and goat (Capra hircus; KM578828) are those displayed here.  Dog and 
goat mRNA sequences were cloned.  Start and Stop codons are identified in green and 
red text, respectively.  Regions identical to human GSTA3 mRNA have been 
highlighted. 
Human      ATGGCAGGGAAGCCCAAGCTTCACTACTTCAATGGACGGGGCAGAATGGAGCCCATCCGG
Horse      ATGGCAGTGAAGCCCATGCTTCACTACTTCAATGGACGAGGCCGGATGGAGCCTATCCGG
Dog ATGGCGGGGAAGCCCAAGCTTCACTACTTCAATGGACGAGGCAGAATGGAGTCCATCCGG
Goat       ATGGCAGGGAAGCCCATTCTTCACTATTTCAATGGACGCGGCAGAATGGAGTGCATTCGG
***** * ********  ******** *********** *** * ******   ** ***
Human      TGGCTCTTGGCTGCAGCTGGAGTGGAGTTTGAAGAGAAATTTATAGGATCTGCAGAAGAT
Horse      TGGCTCCTGGCTGCTGCGGGAGTCGAGTTTGAAGAGACATTTATAGACACTCCAGAAGAC
Dog TGGCTCCTGGCTTCAGCTGGAGTAGAGTTTGAAGAGAAATTTATAAATACTCCAGAAGAC
Goat       TGGCTCCTGGCTGCGGCTGGAGTGGAGTTTGAAGAAAAATTTATAGAAAAACCAGAAGGC
****** ***** * ** ***** *********** * *******       ******  
Human      TTGGGAAAGTTAAGAAATGATGGGAGTTTGATGTTCCAGCAAGTACCAATGGTTGAGATT
Horse      TTTGAAAAGCTAAAAAATGATGGGAGTTTGATGTTCCAGCAAGTGCCAATGGTCGAAATT
Dog TTGGATAAATTAAAAAATGATGGAAGTCTGATGTTCCAGCAAGTGCCAATGGTGGAAATT
Goat       TTGGATAAGTTAAAAAATGATGGGAGTTTGATGTTCCAGCAAGTGCCAATGGCTGAAATT
** *  **  *** ********* *** **************** *******  ** ***
Human      GATGGGATGAAGTTGGTACAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
Horse      GATGGGATGAAGCTGGTGCAGAGCAGAGCCATTCTCAACTATGTTGCCGCCAAACACAAC
Dog GATGGAATGAAGCTGGTACAGGCCAGAGCCATTCTCAACTACATTGCCACCAAATACAAC
Goat       GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATTGCCGCCAAACACAAC
***** ****** **** ***  ******************  *****  **** *****
Human      CTCTACGGGAAAGACATAAAGGAGAGAGCCCTAATTGATATGTATACAGAAGGTATGGCA
Horse      CTCTATGGGAAAGACATCAAGGAGAGAGCCCTGATTGATATGTACATAGAAGGTGTGGCA
Dog CTCTATGGGAAAGACATAAAGGAGAGAGCTCTGATAGATATGTACACAGAAGGTATAGTA
Goat       CTCTACGGGAAAGACATGAAGGAGAGAGCCCTGATTGATATGTACTCAGAGGGTGTGGCA
***** *********** *********** ** ** ********   *** *** * * *
Human      GATTTGAATGAAATGATCCTTCTTCTGCCCTTATGTCGACCTGAGGAAAAAGATGCCAAG
Horse      GATTTGAATGAAATGATCCTGCTTTTACCCATAACCCCACCTGCTGAAAAAGATGCTAAG
Dog GATTTGAATGAAATGATCATGGTTTTGCCTCTATGCCCACCTGATCAAAAAGATGCCAAG
Goat       GATTTGGGTGAAATGATCATGCATTTGCCACTGTGCCCACCTGCTGAAAAAGACGCCAAG
******  ********** *   * * **  *    * *****   ******* ** ***
!81
Figure B-1 Continued 
Human      ATTGCCTTGATCAAAGAGAAAACAAAAAGTCGCTATTTCCCTGCCTTCGAAAAAGTGTTA
Horse      ATTATGCTGATCAAAGACAGAACAACAAATCGTTATTTGCCTGCGTTTGAAAAAGTGTTA
Dog ATTACTCTGATCAGAGAGAGAACAACAGATCGTTATCTCCCCGTGTTTGAAAAAGTGTTA
Goat       CTGACCCTAATCCGAGAAAAGACAACAAACCGTTATCTCCCTGCATTTGAAAATGTGCTG
*     * ***  *** *  **** *   ** *** * ** *  ** ***** *** * 
Human      CAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTAGCCTG
Horse      AAGAGCCACGGAGAAGACTATCTGGTTGGAAACAGGCTGAGCAGGGCTGACATCCACCTG
Dog AAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCAGGGCTGACATTCACCTG
Goat       AAGAGCCACGGACAAGACTACCTGGTGGGCAACAAGCTGAGCAGGGCTGACATCCACCTG
******* *** ******* ** ** ** **** ******* **********   ****
Human      GTGGAACTTCTCTACTATGTGGAAGAGCTTGACTCCAGCCTTATCTCCAACTTCCCTCTG
Horse      GTGGAACTTCTCTACCTTGTTGAAGAGCTTGACCCCAGCCTTCTGACCAACTTCCCTCTG
Dog GTTGAACTTCTCTACTATGTGGAAGAGCTTGACTCCAGCCTTCTGGCCAACTTCCCTCTG
Goat       GTTGAACTTCTCTACTATGTGGAAGAGCTGGACCCTAGCCTTTTGGCCAGCTTCCCTCTG
** ************  *** ******** *** * ****** *  *** **********
Human      CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACGGTGAAGAAGTTTCTACAGCCT
Horse      CTGAAGGCCCTGAAAGCCAGAATCAGCAACCTGCCCACCGTGAAGAAGTTTCTGCAGCCT
Dog CTGAAGGCCCTGAAAACCAGAGTCAGCAATCTCCCCACCGTGAAGAAGTTTCTGCAGCCT
Goat       CTGAAGGCCCTAAAAGCCAGAGTCAGCAATCTCCCGGCCGTGAAGAAGTTTCTGCAGCCC
*********** *** ***** ******* ** **  * ************** ***** 
Human      GGCAGCCCAAGGAAGCCTCCCGCAGATGCAAAAGCTTTAGAAGAAGCCAGAAAGATTTTC
Horse      GGTGGGGCGAGGAAGCCTCCAGGGGATGAGAAATCTGTAGAAAAGTCAAGGAAGATTTTC
Dog GGCAGCCCAAGGAAGCCTCCCTTGGATGAGAAAAGTTTAGAGCAAGCGAAGAAGATTTTC
Goat       GGTAGCCAGAGGAAGCCTCCCACGGACGAGAAAAAAATAGAAGAAGCCAGGAGGGCTTTC
**  *    ***********    ** *  ***    ****  *  * *  * *  ****
Human      AGGTTTTAA
Horse      AAGTTTTGA
Dog AGGATTTAA
Goat       AAGTTTTAA
* * *** *
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APPENDIX C 
Plasmid maps of both pCR2.1 and pET-21a 
Figure C-1 Plasmid map of dog (Canis lupus familiaris) GSTA3-pCR2.1, NCBI 































Figure C-3 Plasmid map of opossum (Monodelphis domestica) GSTA3-pCR 2.1, NCBI 















Figure C-4 Plasmid map of dog (Canis lupus familiaris) GSTA3-pET-21a, NCBI 

































Figure C-6 Plasmid map of opossum (Monodelphis domestica) GSTA3-pET-21a, NCBI 

































APPENDIX D  
GSTA3 mRNA expression normalized by GAPDH mRNA expression determined by real 
time quantitative polymerase chain reaction 
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Table D-1 GSTA3 mRNA levels in equine tissues normalized to GAPDH mRNA 
levels measured by real time quantitative polymerase chain reaction.  The lowest 
value was set to one with all other values relative to that in order to rank the tissues 




Adrenal (1500), Liver (1000)
V
Ovary (500), Small Intestine (225), Kidney Cortex (150)
V




Mammary (2.5), Cerebrum, Skeletal Muscle (1)
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 Table D-2 GSTA3 mRNA levels in canine tissues normalized to GAPDH mRNA 
levels measured by real time quantitative polymerase chain reaction.  The lowest 
value was set to one with all other values relative to that in order to rank the 




Small Intestine (184.7), Adrenal (132)
Testes (71.8)






Skeletal Muscle (4.8), Mammary (3.5), Heart (2.6)
Hypothalamus (1.8), Kidney (1.6), Uterus (1.14), Cerebrum (1)
